




Analysis Type:	PANTHER Overrepresentation Test (Released 20210224)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4735677 Released 2021-05-01
Analyzed List:	Client Text Box Input (Homo sapiens)
Reference List:	Homo sapiens (all genes in database)
Test Type:	FISHER
Correction:	FDR
GO biological process complete	Homo sapiens - REFLIST (20595)	Client Text Box Input (2507)	Client Text Box Input (expected)	Client Text Box Input (over/under)	Client Text Box Input (fold Enrichment)	Client Text Box Input (raw P-value)	Client Text Box Input (FDR)
multicellular organism development (GO:0007275)	4941	1049	601.46	+	1.74	8.39E-76	1.33E-71
anatomical structure development (GO:0048856)	5330	1103	648.81	+	1.70	1.91E-75	1.51E-71
system development (GO:0048731)	4330	958	527.08	+	1.82	3.36E-75	1.77E-71
developmental process (GO:0032502)	5797	1154	705.66	+	1.64	4.37E-71	1.73E-67
multicellular organismal process (GO:0032501)	6926	1285	843.09	+	1.52	3.45E-65	1.09E-61
nervous system development (GO:0007399)	2218	583	269.99	+	2.16	8.68E-62	2.29E-58
anatomical structure morphogenesis (GO:0009653)	2158	562	262.69	+	2.14	5.40E-58	1.22E-54
animal organ development (GO:0048513)	3220	719	391.97	+	1.83	1.60E-53	3.16E-50
cell differentiation (GO:0030154)	3575	772	435.18	+	1.77	3.52E-53	6.18E-50
cellular developmental process (GO:0048869)	3634	777	442.36	+	1.76	3.52E-52	5.57E-49
neurogenesis (GO:0022008)	1391	387	169.32	+	2.29	3.46E-44	4.98E-41
generation of neurons (GO:0048699)	1271	363	154.72	+	2.35	2.35E-43	3.09E-40
animal organ morphogenesis (GO:0009887)	956	300	116.37	+	2.58	7.67E-42	9.33E-39
regulation of multicellular organismal process (GO:0051239)	2673	582	325.38	+	1.79	6.13E-39	6.92E-36
neuron differentiation (GO:0030182)	1043	308	126.96	+	2.43	7.89E-39	8.31E-36
central nervous system development (GO:0007417)	1000	287	121.73	+	2.36	2.54E-34	2.51E-31
regulation of developmental process (GO:0050793)	2461	531	299.57	+	1.77	3.89E-34	3.61E-31
regulation of signaling (GO:0023051)	3545	691	431.53	+	1.60	1.84E-33	1.62E-30
biological regulation (GO:0065007)	12568	1829	1529.88	+	1.20	1.58E-32	1.32E-29
regulation of cell communication (GO:0010646)	3509	681	427.15	+	1.59	2.06E-32	1.55E-29
regulation of localization (GO:0032879)	2753	569	335.12	+	1.70	2.06E-32	1.63E-29
pattern specification process (GO:0007389)	426	165	51.86	+	3.18	2.01E-31	1.45E-28
regulation of biological process (GO:0050789)	11898	1746	1448.33	+	1.21	4.61E-31	3.17E-28
regulation of cellular process (GO:0050794)	11351	1681	1381.74	+	1.22	1.41E-30	9.26E-28
embryo development (GO:0009790)	991	272	120.63	+	2.25	8.12E-30	5.13E-27
positive regulation of cellular process (GO:0048522)	5741	971	698.84	+	1.39	2.52E-28	1.47E-25
cell-cell signaling (GO:0007267)	1131	292	137.68	+	2.12	2.45E-28	1.49E-25
regionalization (GO:0003002)	317	133	38.59	+	3.45	4.00E-28	2.26E-25
cell development (GO:0048468)	1646	377	200.37	+	1.88	7.97E-28	4.34E-25
regulation of biological quality (GO:0065008)	3995	729	486.31	+	1.50	1.01E-27	5.33E-25
positive regulation of biological process (GO:0048518)	6331	1046	770.66	+	1.36	1.07E-27	5.46E-25
regulation of cell differentiation (GO:0045595)	1586	365	193.06	+	1.89	3.14E-27	1.55E-24
cell fate commitment (GO:0045165)	238	112	28.97	+	3.87	4.32E-27	2.07E-24
tissue development (GO:0009888)	1729	384	210.47	+	1.82	4.43E-26	2.00E-23
regulation of multicellular organismal development (GO:2000026)	1332	319	162.14	+	1.97	4.35E-26	2.02E-23
positive regulation of developmental process (GO:0051094)	1271	307	154.72	+	1.98	1.44E-25	6.33E-23
tube development (GO:0035295)	856	233	104.20	+	2.24	3.46E-25	1.48E-22
negative regulation of biological process (GO:0048519)	5501	922	669.63	+	1.38	4.03E-25	1.68E-22
embryonic morphogenesis (GO:0048598)	570	179	69.39	+	2.58	5.30E-25	2.15E-22
anatomical structure formation involved in morphogenesis (GO:0048646)	883	237	107.49	+	2.20	8.49E-25	3.35E-22
negative regulation of cellular process (GO:0048523)	4902	839	596.71	+	1.41	9.71E-25	3.74E-22
head development (GO:0060322)	803	222	97.75	+	2.27	1.00E-24	3.76E-22
regulation of transport (GO:0051049)	1772	383	215.70	+	1.78	4.12E-24	1.51E-21
behavior (GO:0007610)	557	173	67.80	+	2.55	7.76E-24	2.79E-21
brain development (GO:0007420)	759	211	92.39	+	2.28	8.68E-24	3.05E-21
sensory organ development (GO:0007423)	555	172	67.56	+	2.55	1.25E-23	4.30E-21
positive regulation of multicellular organismal process (GO:0051240)	1431	326	174.19	+	1.87	1.48E-23	4.99E-21
regulation of ion transport (GO:0043269)	703	200	85.58	+	2.34	1.80E-23	5.92E-21
signaling (GO:0023052)	5565	919	677.42	+	1.36	4.37E-23	1.41E-20
nucleic acid metabolic process (GO:0090304)	2217	124	269.87	-	.46	4.75E-23	1.50E-20
embryonic organ development (GO:0048568)	435	145	52.95	+	2.74	2.41E-22	7.31E-20
circulatory system development (GO:0072359)	877	228	106.76	+	2.14	2.37E-22	7.34E-20
positive regulation of cell differentiation (GO:0045597)	840	221	102.25	+	2.16	2.69E-22	8.02E-20
neuron development (GO:0048666)	846	221	102.98	+	2.15	5.87E-22	1.72E-19
cell communication (GO:0007154)	5656	922	688.50	+	1.34	1.39E-21	3.99E-19
modulation of chemical synaptic transmission (GO:0050804)	431	141	52.47	+	2.69	2.70E-21	7.62E-19
regulation of signal transduction (GO:0009966)	3128	573	380.77	+	1.50	2.75E-21	7.64E-19
regulation of trans-synaptic signaling (GO:0099177)	432	141	52.59	+	2.68	3.15E-21	8.59E-19
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	441	1	53.68	-	.02	4.65E-21	1.24E-18
heterocycle metabolic process (GO:0046483)	2891	193	351.92	-	.55	8.87E-21	2.34E-18
tube morphogenesis (GO:0035239)	654	182	79.61	+	2.29	1.36E-20	3.53E-18
regulation of system process (GO:0044057)	585	168	71.21	+	2.36	3.71E-20	9.47E-18
positive regulation of transcription by RNA polymerase II (GO:0045944)	1212	277	147.54	+	1.88	4.05E-20	1.02E-17
nucleobase-containing compound metabolic process (GO:0006139)	2705	178	329.28	-	.54	4.64E-20	1.15E-17
cellular nitrogen compound metabolic process (GO:0034641)	3395	245	413.27	-	.59	5.38E-20	1.31E-17
detection of chemical stimulus involved in sensory perception (GO:0050907)	486	4	59.16	-	.07	1.83E-19	4.39E-17
tissue morphogenesis (GO:0048729)	545	158	66.34	+	2.38	2.14E-19	5.05E-17
regulation of transcription by RNA polymerase II (GO:0006357)	2595	485	315.89	+	1.54	3.79E-19	8.80E-17
negative regulation of developmental process (GO:0051093)	879	216	107.00	+	2.02	7.23E-19	1.66E-16
forebrain development (GO:0030900)	387	125	47.11	+	2.65	1.27E-18	2.86E-16
embryonic organ morphogenesis (GO:0048562)	295	106	35.91	+	2.95	1.51E-18	3.36E-16
regulation of cell population proliferation (GO:0042127)	1654	340	201.34	+	1.69	1.98E-18	4.34E-16
positive regulation of transcription, DNA-templated (GO:0045893)	1628	335	198.17	+	1.69	4.21E-18	8.99E-16
positive regulation of RNA biosynthetic process (GO:1902680)	1629	335	198.30	+	1.69	4.28E-18	9.03E-16
positive regulation of nucleic acid-templated transcription (GO:1903508)	1628	335	198.17	+	1.69	4.21E-18	9.11E-16
trans-synaptic signaling (GO:0099537)	432	132	52.59	+	2.51	5.82E-18	1.21E-15
cellular aromatic compound metabolic process (GO:0006725)	2937	209	357.52	-	.58	7.27E-18	1.49E-15
RNA processing (GO:0006396)	930	33	113.21	-	.29	8.96E-18	1.82E-15
synaptic signaling (GO:0099536)	464	138	56.48	+	2.44	1.02E-17	2.05E-15
skeletal system development (GO:0001501)	479	140	58.31	+	2.40	1.67E-17	3.31E-15
nitrogen compound metabolic process (GO:0006807)	6886	631	838.22	-	.75	2.18E-17	4.25E-15
regulation of response to stimulus (GO:0048583)	4306	714	524.16	+	1.36	3.31E-17	6.38E-15
gene expression (GO:0010467)	2117	134	257.70	-	.52	4.64E-17	8.84E-15
anterior/posterior pattern specification (GO:0009952)	203	82	24.71	+	3.32	4.72E-17	8.89E-15
neuron projection development (GO:0031175)	691	177	84.11	+	2.10	6.24E-17	1.16E-14
positive regulation of metabolic process (GO:0009893)	3820	646	465.00	+	1.39	6.51E-17	1.18E-14
neuron projection morphogenesis (GO:0048812)	499	142	60.74	+	2.34	6.48E-17	1.19E-14
central nervous system neuron differentiation (GO:0021953)	183	77	22.28	+	3.46	7.16E-17	1.27E-14
epithelium development (GO:0060429)	1113	248	135.48	+	1.83	7.08E-17	1.27E-14
cell morphogenesis (GO:0000902)	715	181	87.04	+	2.08	7.41E-17	1.30E-14
plasma membrane bounded cell projection morphogenesis (GO:0120039)	503	142	61.23	+	2.32	9.24E-17	1.61E-14
anterograde trans-synaptic signaling (GO:0098916)	414	125	50.40	+	2.48	1.38E-16	2.35E-14
chemical synaptic transmission (GO:0007268)	414	125	50.40	+	2.48	1.38E-16	2.37E-14
cell projection morphogenesis (GO:0048858)	507	142	61.72	+	2.30	1.86E-16	3.12E-14
regulation of nervous system development (GO:0051960)	443	130	53.93	+	2.41	2.10E-16	3.46E-14
positive regulation of RNA metabolic process (GO:0051254)	1773	349	215.82	+	1.62	2.13E-16	3.47E-14
heart development (GO:0007507)	535	147	65.12	+	2.26	2.09E-16	3.48E-14
regulation of ion transmembrane transport (GO:0034765)	502	141	61.11	+	2.31	2.31E-16	3.72E-14
system process (GO:0003008)	2057	391	250.40	+	1.56	2.73E-16	4.31E-14
primary metabolic process (GO:0044238)	7352	691	894.95	-	.77	2.70E-16	4.31E-14
urogenital system development (GO:0001655)	324	106	39.44	+	2.69	3.24E-16	5.07E-14
organic cyclic compound metabolic process (GO:1901360)	3182	241	387.34	-	.62	4.39E-16	6.80E-14
macromolecule metabolic process (GO:0043170)	6151	558	748.75	-	.75	6.55E-16	1.01E-13
axon development (GO:0061564)	421	124	51.25	+	2.42	7.41E-16	1.13E-13
cellular metabolic process (GO:0044237)	7542	717	918.08	-	.78	1.02E-15	1.53E-13
cell part morphogenesis (GO:0032990)	526	143	64.03	+	2.23	1.02E-15	1.54E-13
positive regulation of cellular metabolic process (GO:0031325)	3314	568	403.41	+	1.41	1.22E-15	1.80E-13
regulation of membrane potential (GO:0042391)	437	126	53.20	+	2.37	1.42E-15	2.08E-13
cellular component morphogenesis (GO:0032989)	611	158	74.38	+	2.12	1.61E-15	2.33E-13
regulation of transmembrane transport (GO:0034762)	591	154	71.94	+	2.14	1.68E-15	2.42E-13
renal system development (GO:0072001)	291	97	35.42	+	2.74	2.35E-15	3.32E-13
positive regulation of cell communication (GO:0010647)	1755	341	213.63	+	1.60	2.34E-15	3.34E-13
positive regulation of signaling (GO:0023056)	1761	342	214.36	+	1.60	2.52E-15	3.53E-13
positive regulation of nitrogen compound metabolic process (GO:0051173)	3123	539	380.16	+	1.42	2.73E-15	3.79E-13
negative regulation of cell differentiation (GO:0045596)	644	163	78.39	+	2.08	2.95E-15	4.05E-13
negative regulation of signaling (GO:0023057)	1405	287	171.03	+	1.68	3.08E-15	4.20E-13
positive regulation of macromolecule metabolic process (GO:0010604)	3522	594	428.73	+	1.39	3.46E-15	4.68E-13
cell morphogenesis involved in neuron differentiation (GO:0048667)	453	128	55.14	+	2.32	3.71E-15	4.97E-13
circulatory system process (GO:0003013)	481	133	58.55	+	2.27	4.28E-15	5.68E-13
negative regulation of response to stimulus (GO:0048585)	1831	351	222.89	+	1.57	5.41E-15	7.13E-13
regulation of secretion (GO:0051046)	639	161	77.78	+	2.07	5.83E-15	7.61E-13
mRNA metabolic process (GO:0016071)	697	22	84.84	-	.26	6.26E-15	8.12E-13
locomotion (GO:0040011)	1345	276	163.72	+	1.69	6.58E-15	8.46E-13
negative regulation of cell communication (GO:0010648)	1401	285	170.54	+	1.67	7.34E-15	9.36E-13
axonogenesis (GO:0007409)	385	114	46.87	+	2.43	9.03E-15	1.14E-12
cell fate specification (GO:0001708)	81	47	9.86	+	4.77	1.08E-14	1.35E-12
negative regulation of multicellular organismal process (GO:0051241)	1014	223	123.43	+	1.81	1.09E-14	1.35E-12
RNA metabolic process (GO:0016070)	1582	94	192.57	-	.49	1.20E-14	1.49E-12
muscle structure development (GO:0061061)	473	130	57.58	+	2.26	1.26E-14	1.55E-12
cell morphogenesis involved in differentiation (GO:0000904)	559	145	68.05	+	2.13	1.59E-14	1.93E-12
regulation of locomotion (GO:0040012)	997	219	121.36	+	1.80	2.05E-14	2.47E-12
sensory organ morphogenesis (GO:0090596)	261	88	31.77	+	2.77	2.39E-14	2.86E-12
morphogenesis of an epithelium (GO:0002009)	441	123	53.68	+	2.29	2.57E-14	3.05E-12
extracellular matrix organization (GO:0030198)	383	112	46.62	+	2.40	2.61E-14	3.08E-12
detection of chemical stimulus (GO:0009593)	522	12	63.54	-	.19	2.89E-14	3.38E-12
extracellular structure organization (GO:0043062)	384	112	46.74	+	2.40	2.92E-14	3.39E-12
regulation of neuron differentiation (GO:0045664)	193	73	23.49	+	3.11	3.62E-14	4.18E-12
regulation of anatomical structure morphogenesis (GO:0022603)	967	213	117.71	+	1.81	3.92E-14	4.49E-12
organic substance metabolic process (GO:0071704)	7840	763	954.35	-	.80	4.78E-14	5.44E-12
sensory perception of smell (GO:0007608)	468	9	56.97	-	.16	4.84E-14	5.47E-12
inorganic ion transmembrane transport (GO:0098660)	637	157	77.54	+	2.02	5.15E-14	5.77E-12
external encapsulating structure organization (GO:0045229)	386	112	46.99	+	2.38	5.27E-14	5.86E-12
regulation of secretion by cell (GO:1903530)	581	147	70.72	+	2.08	6.59E-14	7.28E-12
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1941	361	236.28	+	1.53	7.31E-14	7.96E-12
blood circulation (GO:0008015)	390	112	47.47	+	2.36	7.30E-14	8.02E-12
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	222	79	27.02	+	2.92	7.46E-14	8.08E-12
neuron projection guidance (GO:0097485)	278	90	33.84	+	2.66	7.91E-14	8.45E-12
positive regulation of cellular biosynthetic process (GO:0031328)	1969	365	239.68	+	1.52	7.89E-14	8.49E-12
regulation of cell development (GO:0060284)	500	132	60.86	+	2.17	9.35E-14	9.92E-12
regulation of neurogenesis (GO:0050767)	364	107	44.31	+	2.41	1.07E-13	1.13E-11
positive regulation of biosynthetic process (GO:0009891)	2004	369	243.94	+	1.51	1.22E-13	1.28E-11
chemotaxis (GO:0006935)	547	140	66.59	+	2.10	1.38E-13	1.43E-11
movement of cell or subcellular component (GO:0006928)	1596	308	194.28	+	1.59	1.54E-13	1.59E-11
taxis (GO:0042330)	550	140	66.95	+	2.09	1.65E-13	1.69E-11
cellular macromolecule catabolic process (GO:0044265)	925	42	112.60	-	.37	1.82E-13	1.85E-11
kidney development (GO:0001822)	282	90	34.33	+	2.62	1.84E-13	1.86E-11
regulation of cellular component movement (GO:0051270)	1032	220	125.62	+	1.75	2.09E-13	2.10E-11
axon guidance (GO:0007411)	277	89	33.72	+	2.64	2.18E-13	2.18E-11
positive regulation of macromolecule biosynthetic process (GO:0010557)	1863	347	226.78	+	1.53	2.26E-13	2.25E-11
signal transduction (GO:0007165)	5227	810	636.28	+	1.27	2.73E-13	2.70E-11
cellular protein-containing complex assembly (GO:0034622)	867	38	105.54	-	.36	3.45E-13	3.39E-11
neuropeptide signaling pathway (GO:0007218)	109	51	13.27	+	3.84	5.17E-13	5.05E-11
cellular macromolecule metabolic process (GO:0044260)	4909	440	597.57	-	.74	5.57E-13	5.40E-11
chordate embryonic development (GO:0043009)	613	149	74.62	+	2.00	6.18E-13	5.96E-11
metabolic process (GO:0008152)	8313	827	1011.93	-	.82	6.46E-13	6.19E-11
ion transmembrane transport (GO:0034220)	870	192	105.90	+	1.81	6.63E-13	6.31E-11
blood vessel development (GO:0001568)	492	128	59.89	+	2.14	6.79E-13	6.42E-11
ion transport (GO:0006811)	1200	244	146.07	+	1.67	7.63E-13	7.18E-11
embryo development ending in birth or egg hatching (GO:0009792)	633	152	77.05	+	1.97	8.59E-13	8.03E-11
regulation of RNA biosynthetic process (GO:2001141)	3480	572	423.62	+	1.35	9.59E-13	8.92E-11
inorganic cation transmembrane transport (GO:0098662)	573	141	69.75	+	2.02	1.13E-12	1.04E-10
biological adhesion (GO:0022610)	959	205	116.74	+	1.76	1.16E-12	1.07E-10
ear development (GO:0043583)	220	75	26.78	+	2.80	1.19E-12	1.09E-10
blood vessel morphogenesis (GO:0048514)	410	112	49.91	+	2.24	1.21E-12	1.09E-10
vasculature development (GO:0001944)	514	131	62.57	+	2.09	1.20E-12	1.09E-10
cell adhesion (GO:0007155)	953	204	116.01	+	1.76	1.36E-12	1.22E-10
regulation of transcription, DNA-templated (GO:0006355)	3474	570	422.89	+	1.35	1.39E-12	1.23E-10
regulation of cation transmembrane transport (GO:1904062)	378	106	46.01	+	2.30	1.38E-12	1.23E-10
regulation of nucleic acid-templated transcription (GO:1903506)	3475	570	423.01	+	1.35	1.41E-12	1.24E-10
cation transport (GO:0006812)	824	183	100.30	+	1.82	1.68E-12	1.47E-10
negative regulation of transcription by RNA polymerase II (GO:0000122)	906	196	110.29	+	1.78	1.71E-12	1.50E-10
cation transmembrane transport (GO:0098655)	641	152	78.03	+	1.95	1.79E-12	1.56E-10
negative regulation of transcription, DNA-templated (GO:0045892)	1297	257	157.88	+	1.63	1.84E-12	1.59E-10
response to endogenous stimulus (GO:0009719)	1426	277	173.58	+	1.60	1.91E-12	1.64E-10
cellular response to stimulus (GO:0051716)	6807	1007	828.61	+	1.22	2.09E-12	1.78E-10
protein-containing complex subunit organization (GO:0043933)	1605	104	195.37	-	.53	2.12E-12	1.80E-10
potassium ion transmembrane transport (GO:0071805)	158	61	19.23	+	3.17	2.24E-12	1.90E-10
organelle organization (GO:0006996)	3567	300	434.21	-	.69	2.32E-12	1.95E-10
gland development (GO:0048732)	414	112	50.40	+	2.22	2.46E-12	2.04E-10
regulation of cell migration (GO:0030334)	892	193	108.58	+	1.78	2.45E-12	2.05E-10
negative regulation of nucleic acid-templated transcription (GO:1903507)	1299	257	158.13	+	1.63	2.48E-12	2.05E-10
negative regulation of RNA biosynthetic process (GO:1902679)	1301	257	158.37	+	1.62	2.60E-12	2.14E-10
regulation of cell motility (GO:2000145)	954	203	116.13	+	1.75	2.75E-12	2.25E-10
macromolecule catabolic process (GO:0009057)	1058	56	128.79	-	.43	3.21E-12	2.62E-10
response to oxygen-containing compound (GO:1901700)	1604	302	195.25	+	1.55	3.63E-12	2.94E-10
negative regulation of signal transduction (GO:0009968)	1305	257	158.86	+	1.62	3.70E-12	2.97E-10
spinal cord development (GO:0021510)	100	47	12.17	+	3.86	3.69E-12	2.98E-10
neuron fate commitment (GO:0048663)	62	37	7.55	+	4.90	3.83E-12	3.06E-10
cellular response to chemical stimulus (GO:0070887)	2914	489	354.72	+	1.38	4.84E-12	3.84E-10
response to stimulus (GO:0050896)	8540	1221	1039.56	+	1.17	5.92E-12	4.68E-10
skeletal system morphogenesis (GO:0048705)	224	74	27.27	+	2.71	6.28E-12	4.94E-10
cellular response to endogenous stimulus (GO:0071495)	1152	232	140.23	+	1.65	6.87E-12	5.38E-10
endocrine system development (GO:0035270)	124	52	15.09	+	3.44	8.15E-12	6.35E-10
regulation of hormone levels (GO:0010817)	538	132	65.49	+	2.02	8.30E-12	6.43E-10
reproductive system development (GO:0061458)	419	111	51.00	+	2.18	8.62E-12	6.65E-10
camera-type eye development (GO:0043010)	317	92	38.59	+	2.38	9.67E-12	7.42E-10
epithelial tube morphogenesis (GO:0060562)	309	90	37.61	+	2.39	1.09E-11	8.30E-10
reproductive structure development (GO:0048608)	416	110	50.64	+	2.17	1.20E-11	9.10E-10
positive regulation of nervous system development (GO:0051962)	274	83	33.35	+	2.49	1.36E-11	1.03E-09
sensory system development (GO:0048880)	374	102	45.53	+	2.24	1.46E-11	1.10E-09
locomotory behavior (GO:0007626)	181	64	22.03	+	2.90	1.49E-11	1.11E-09
telencephalon development (GO:0021537)	254	79	30.92	+	2.56	1.51E-11	1.13E-09
potassium ion transport (GO:0006813)	167	61	20.33	+	3.00	1.82E-11	1.35E-09
cellular process (GO:0009987)	15495	2035	1886.18	+	1.08	1.96E-11	1.45E-09
response to organic substance (GO:0010033)	3008	498	366.16	+	1.36	1.98E-11	1.46E-09
cognition (GO:0050890)	298	87	36.28	+	2.40	2.43E-11	1.78E-09
regulation of blood circulation (GO:1903522)	278	83	33.84	+	2.45	3.03E-11	2.21E-09
heart morphogenesis (GO:0003007)	241	76	29.34	+	2.59	3.07E-11	2.22E-09
response to chemical (GO:0042221)	4381	682	533.29	+	1.28	3.31E-11	2.39E-09
muscle tissue development (GO:0060537)	301	87	36.64	+	2.37	3.34E-11	2.40E-09
neuron migration (GO:0001764)	117	49	14.24	+	3.44	3.35E-11	2.40E-09
inner ear development (GO:0048839)	195	66	23.74	+	2.78	3.53E-11	2.52E-09
nephron development (GO:0072006)	126	51	15.34	+	3.33	3.59E-11	2.55E-09
eye development (GO:0001654)	364	99	44.31	+	2.23	3.75E-11	2.65E-09
regulation of RNA metabolic process (GO:0051252)	3782	601	460.38	+	1.31	4.30E-11	3.02E-09
regulation of hormone secretion (GO:0046883)	276	82	33.60	+	2.44	4.67E-11	3.27E-09
visual system development (GO:0150063)	368	99	44.80	+	2.21	4.96E-11	3.45E-09
sensory perception of chemical stimulus (GO:0007606)	543	19	66.10	-	.29	6.34E-11	4.40E-09
negative regulation of RNA metabolic process (GO:0051253)	1408	266	171.39	+	1.55	7.14E-11	4.93E-09
cellular protein metabolic process (GO:0044267)	3590	312	437.01	-	.71	9.30E-11	6.39E-09
striated muscle tissue development (GO:0014706)	286	83	34.81	+	2.38	9.59E-11	6.56E-09
chemical homeostasis (GO:0048878)	1139	224	138.65	+	1.62	1.10E-10	7.52E-09
positive regulation of ion transport (GO:0043270)	297	85	36.15	+	2.35	1.17E-10	7.91E-09
regulation of neuron projection development (GO:0010975)	447	112	54.41	+	2.06	1.32E-10	8.94E-09
regulation of plasma membrane bounded cell projection organization (GO:0120035)	631	143	76.81	+	1.86	1.45E-10	9.73E-09
regulation of nitrogen compound metabolic process (GO:0051171)	5740	854	698.72	+	1.22	1.79E-10	1.20E-08
DNA metabolic process (GO:0006259)	777	38	94.58	-	.40	2.05E-10	1.36E-08
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	134	51	16.31	+	3.13	2.09E-10	1.39E-08
regulation of cation channel activity (GO:2001257)	186	62	22.64	+	2.74	2.23E-10	1.48E-08
divalent inorganic cation homeostasis (GO:0072507)	481	117	58.55	+	2.00	2.25E-10	1.48E-08
regulation of cell projection organization (GO:0031344)	648	145	78.88	+	1.84	2.38E-10	1.56E-08
mRNA processing (GO:0006397)	486	16	59.16	-	.27	2.43E-10	1.58E-08
ion homeostasis (GO:0050801)	773	165	94.10	+	1.75	2.65E-10	1.72E-08
regulation of cellular metabolic process (GO:0031323)	6138	903	747.17	+	1.21	2.94E-10	1.90E-08
regulation of primary metabolic process (GO:0080090)	5925	876	721.24	+	1.21	3.04E-10	1.96E-08
digestive system development (GO:0055123)	136	51	16.56	+	3.08	3.17E-10	2.04E-08
regulation of peptide secretion (GO:0002791)	226	70	27.51	+	2.54	3.26E-10	2.09E-08
regulation of neurotransmitter levels (GO:0001505)	218	68	26.54	+	2.56	3.38E-10	2.15E-08
positive regulation of cell population proliferation (GO:0008284)	939	191	114.30	+	1.67	3.64E-10	2.31E-08
regulation of peptide transport (GO:0090087)	228	70	27.75	+	2.52	3.85E-10	2.44E-08
regulation of metabolic process (GO:0019222)	6874	996	836.76	+	1.19	3.96E-10	2.49E-08
ncRNA metabolic process (GO:0034660)	521	19	63.42	-	.30	4.36E-10	2.74E-08
cell migration (GO:0016477)	968	195	117.83	+	1.65	4.63E-10	2.90E-08
vascular process in circulatory system (GO:0003018)	251	74	30.55	+	2.42	4.66E-10	2.90E-08
ear morphogenesis (GO:0042471)	120	47	14.61	+	3.22	4.97E-10	3.08E-08
ribonucleoprotein complex biogenesis (GO:0022613)	462	15	56.24	-	.27	5.89E-10	3.64E-08
kidney epithelium development (GO:0072073)	126	48	15.34	+	3.13	6.85E-10	4.22E-08
metanephros development (GO:0001656)	79	37	9.62	+	3.85	7.60E-10	4.66E-08
adaptive immune response (GO:0002250)	658	30	80.10	-	.37	7.71E-10	4.71E-08
positive regulation of signal transduction (GO:0009967)	1584	286	192.82	+	1.48	7.79E-10	4.72E-08
regulation of peptide hormone secretion (GO:0090276)	222	68	27.02	+	2.52	7.77E-10	4.73E-08
regulation of synaptic plasticity (GO:0048167)	188	61	22.88	+	2.67	8.63E-10	5.21E-08
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	1540	279	187.46	+	1.49	9.97E-10	5.99E-08
positive regulation of transport (GO:0051050)	947	190	115.28	+	1.65	1.06E-09	6.33E-08
negative regulation of macromolecule biosynthetic process (GO:0010558)	1551	280	188.80	+	1.48	1.14E-09	6.82E-08
Unclassified (UNCLASSIFIED)	2744	230	334.02	-	.69	1.24E-09	7.32E-08
biological_process (GO:0008150)	17851	2277	2172.98	+	1.05	1.24E-09	7.35E-08
pancreas development (GO:0031016)	69	34	8.40	+	4.05	1.33E-09	7.87E-08
plasma membrane bounded cell projection organization (GO:0120036)	1175	224	143.03	+	1.57	1.36E-09	8.01E-08
ncRNA processing (GO:0034470)	436	14	53.07	-	.26	1.38E-09	8.07E-08
regulation of biosynthetic process (GO:0009889)	4226	648	514.42	+	1.26	1.47E-09	8.58E-08
negative regulation of cellular biosynthetic process (GO:0031327)	1610	288	195.98	+	1.47	1.64E-09	9.52E-08
translation (GO:0006412)	387	11	47.11	-	.23	1.73E-09	9.99E-08
digestive tract development (GO:0048565)	126	47	15.34	+	3.06	1.78E-09	1.03E-07
mesenchyme development (GO:0060485)	224	67	27.27	+	2.46	1.90E-09	1.09E-07
cellular divalent inorganic cation homeostasis (GO:0072503)	460	110	56.00	+	1.96	1.91E-09	1.09E-07
regulation of cellular biosynthetic process (GO:0031326)	4163	639	506.76	+	1.26	1.93E-09	1.10E-07
calcium ion homeostasis (GO:0055074)	438	106	53.32	+	1.99	1.94E-09	1.10E-07
negative regulation of biosynthetic process (GO:0009890)	1643	292	200.00	+	1.46	2.27E-09	1.29E-07
transmembrane transport (GO:0055085)	1276	238	155.33	+	1.53	2.41E-09	1.36E-07
embryonic skeletal system development (GO:0048706)	123	46	14.97	+	3.07	2.47E-09	1.39E-07
protein-containing complex assembly (GO:0065003)	1358	93	165.31	-	.56	2.61E-09	1.46E-07
regulation of heart contraction (GO:0008016)	230	68	28.00	+	2.43	2.61E-09	1.46E-07
intracellular transport (GO:0046907)	1464	103	178.21	-	.58	2.60E-09	1.46E-07
regulation of synapse structure or activity (GO:0050803)	221	66	26.90	+	2.45	2.66E-09	1.48E-07
synapse organization (GO:0050808)	289	79	35.18	+	2.25	2.83E-09	1.57E-07
cellular response to organic substance (GO:0071310)	2344	391	285.33	+	1.37	2.85E-09	1.57E-07
regulation of ion transmembrane transporter activity (GO:0032412)	272	76	33.11	+	2.30	2.87E-09	1.58E-07
learning or memory (GO:0007611)	256	73	31.16	+	2.34	3.04E-09	1.66E-07
regulation of synapse organization (GO:0050807)	210	64	25.56	+	2.50	3.20E-09	1.74E-07
angiogenesis (GO:0001525)	318	84	38.71	+	2.17	3.22E-09	1.75E-07
cell projection organization (GO:0030030)	1221	229	148.63	+	1.54	3.34E-09	1.81E-07
regulation of macromolecule metabolic process (GO:0060255)	6340	919	771.76	+	1.19	3.49E-09	1.88E-07
response to growth factor (GO:0070848)	526	120	64.03	+	1.87	3.66E-09	1.97E-07
positive regulation of neurogenesis (GO:0050769)	227	67	27.63	+	2.42	3.69E-09	1.97E-07
cell junction organization (GO:0034330)	502	116	61.11	+	1.90	3.68E-09	1.97E-07
nephron epithelium development (GO:0072009)	98	40	11.93	+	3.35	3.73E-09	1.99E-07
regulation of growth (GO:0040008)	661	142	80.46	+	1.76	4.09E-09	2.17E-07
forebrain generation of neurons (GO:0021872)	62	31	7.55	+	4.11	5.39E-09	2.85E-07
muscle organ development (GO:0007517)	283	77	34.45	+	2.24	5.52E-09	2.90E-07
regulation of transmembrane transporter activity (GO:0022898)	283	77	34.45	+	2.24	5.52E-09	2.91E-07
negative regulation of cell population proliferation (GO:0008285)	703	148	85.58	+	1.73	5.63E-09	2.95E-07
positive regulation of phosphate metabolic process (GO:0045937)	998	194	121.49	+	1.60	6.00E-09	3.12E-07
positive regulation of phosphorus metabolic process (GO:0010562)	998	194	121.49	+	1.60	6.00E-09	3.13E-07
DNA repair (GO:0006281)	531	22	64.64	-	.34	6.19E-09	3.21E-07
forebrain neuron differentiation (GO:0021879)	51	28	6.21	+	4.51	6.22E-09	3.22E-07
cellular calcium ion homeostasis (GO:0006874)	425	102	51.73	+	1.97	6.25E-09	3.22E-07
response to lipid (GO:0033993)	831	168	101.16	+	1.66	6.29E-09	3.23E-07
feeding behavior (GO:0007631)	83	36	10.10	+	3.56	6.34E-09	3.25E-07
inorganic ion homeostasis (GO:0098771)	724	151	88.13	+	1.71	6.50E-09	3.31E-07
cellular response to growth factor stimulus (GO:0071363)	497	114	60.50	+	1.88	6.84E-09	3.47E-07
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1528	272	186.00	+	1.46	7.44E-09	3.77E-07
regulation of macromolecule biosynthetic process (GO:0010556)	3999	612	486.79	+	1.26	7.63E-09	3.85E-07
sensory perception of mechanical stimulus (GO:0050954)	177	56	21.55	+	2.60	8.13E-09	4.09E-07
regulation of cellular macromolecule biosynthetic process (GO:2000112)	3968	607	483.02	+	1.26	9.47E-09	4.75E-07
regulation of cytosolic calcium ion concentration (GO:0051480)	321	83	39.07	+	2.12	9.61E-09	4.81E-07
connective tissue development (GO:0061448)	202	61	24.59	+	2.48	9.96E-09	4.97E-07
cell motility (GO:0048870)	1109	209	135.00	+	1.55	1.06E-08	5.24E-07
localization of cell (GO:0051674)	1109	209	135.00	+	1.55	1.06E-08	5.26E-07
cell differentiation in spinal cord (GO:0021515)	49	27	5.96	+	4.53	1.09E-08	5.39E-07
cardiac muscle tissue development (GO:0048738)	168	54	20.45	+	2.64	1.15E-08	5.66E-07
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	303	7	36.88	-	.19	1.16E-08	5.70E-07
mRNA splicing, via spliceosome (GO:0000398)	303	7	36.88	-	.19	1.16E-08	5.72E-07
regulation of nucleobase-containing compound metabolic process (GO:0019219)	4049	617	492.88	+	1.25	1.21E-08	5.91E-07
RNA splicing, via transesterification reactions (GO:0000375)	306	7	37.25	-	.19	1.22E-08	5.92E-07
morphogenesis of a branching epithelium (GO:0061138)	160	52	19.48	+	2.67	1.25E-08	6.05E-07
cell surface receptor signaling pathway (GO:0007166)	2495	407	303.71	+	1.34	1.26E-08	6.08E-07
morphogenesis of a branching structure (GO:0001763)	169	54	20.57	+	2.62	1.27E-08	6.12E-07
cellular protein catabolic process (GO:0044257)	644	32	78.39	-	.41	1.27E-08	6.13E-07
regulation of tube size (GO:0035150)	131	46	15.95	+	2.88	1.34E-08	6.43E-07
positive regulation of cell development (GO:0010720)	300	79	36.52	+	2.16	1.40E-08	6.65E-07
regulation of transporter activity (GO:0032409)	300	79	36.52	+	2.16	1.40E-08	6.67E-07
proteolysis involved in cellular protein catabolic process (GO:0051603)	609	29	74.13	-	.39	1.43E-08	6.79E-07
immune response (GO:0006955)	2075	167	252.59	-	.66	1.51E-08	7.15E-07
regulation of developmental growth (GO:0048638)	320	82	38.95	+	2.11	1.52E-08	7.17E-07
homeostatic process (GO:0042592)	1680	292	204.50	+	1.43	1.54E-08	7.24E-07
limbic system development (GO:0021761)	109	41	13.27	+	3.09	1.56E-08	7.33E-07
negative regulation of neuron differentiation (GO:0045665)	70	32	8.52	+	3.76	1.64E-08	7.66E-07
enzyme linked receptor protein signaling pathway (GO:0007167)	723	149	88.01	+	1.69	1.66E-08	7.75E-07
cation homeostasis (GO:0055080)	710	147	86.43	+	1.70	1.74E-08	8.08E-07
regulation of nervous system process (GO:0031644)	146	49	17.77	+	2.76	1.76E-08	8.18E-07
regulation of protein phosphorylation (GO:0001932)	1218	224	148.27	+	1.51	1.93E-08	8.90E-07
diencephalon development (GO:0021536)	79	34	9.62	+	3.54	1.93E-08	8.91E-07
inner ear morphogenesis (GO:0042472)	101	39	12.29	+	3.17	1.97E-08	9.03E-07
regulation of blood pressure (GO:0008217)	188	57	22.88	+	2.49	2.11E-08	9.66E-07
positive regulation of phosphorylation (GO:0042327)	921	179	112.11	+	1.60	2.25E-08	1.03E-06
neurotransmitter transport (GO:0006836)	142	48	17.29	+	2.78	2.30E-08	1.05E-06
response to retinoic acid (GO:0032526)	111	41	13.51	+	3.03	2.36E-08	1.07E-06
regulation of insulin secretion (GO:0050796)	189	57	23.01	+	2.48	2.39E-08	1.08E-06
cardiac chamber morphogenesis (GO:0003206)	119	43	14.49	+	2.97	2.60E-08	1.17E-06
regulation of tube diameter (GO:0035296)	130	45	15.82	+	2.84	2.62E-08	1.17E-06
blood vessel diameter maintenance (GO:0097746)	130	45	15.82	+	2.84	2.62E-08	1.18E-06
dorsal/ventral pattern formation (GO:0009953)	76	33	9.25	+	3.57	2.62E-08	1.18E-06
peptide biosynthetic process (GO:0043043)	414	15	50.40	-	.30	2.81E-08	1.25E-06
formation of primary germ layer (GO:0001704)	112	41	13.63	+	3.01	2.89E-08	1.29E-06
response to organic cyclic compound (GO:0014070)	900	175	109.56	+	1.60	2.90E-08	1.29E-06
regulation of gene expression (GO:0010468)	4922	728	599.15	+	1.22	2.98E-08	1.32E-06
regulation of phosphorylation (GO:0042325)	1391	248	169.32	+	1.46	3.10E-08	1.37E-06
renal tubule development (GO:0061326)	81	34	9.86	+	3.45	3.13E-08	1.38E-06
mitochondrion organization (GO:0007005)	468	19	56.97	-	.33	3.51E-08	1.54E-06
branching morphogenesis of an epithelial tube (GO:0048754)	132	45	16.07	+	2.80	3.68E-08	1.61E-06
metal ion homeostasis (GO:0055065)	626	132	76.20	+	1.73	3.71E-08	1.62E-06
segmentation (GO:0035282)	95	37	11.56	+	3.20	3.76E-08	1.63E-06
positive regulation of neuron differentiation (GO:0045666)	95	37	11.56	+	3.20	3.76E-08	1.64E-06
positive regulation of protein phosphorylation (GO:0001934)	838	165	102.01	+	1.62	4.24E-08	1.84E-06
cardiac chamber development (GO:0003205)	162	51	19.72	+	2.59	4.57E-08	1.98E-06
protein catabolic process (GO:0030163)	697	38	84.84	-	.45	4.79E-08	2.06E-06
embryonic pattern specification (GO:0009880)	70	31	8.52	+	3.64	4.82E-08	2.07E-06
developmental process involved in reproduction (GO:0003006)	974	185	118.56	+	1.56	5.08E-08	2.18E-06
regulation of anatomical structure size (GO:0090066)	514	113	62.57	+	1.81	5.17E-08	2.21E-06
gastrulation (GO:0007369)	157	50	19.11	+	2.62	5.28E-08	2.25E-06
cellular response to oxygen-containing compound (GO:1901701)	1075	200	130.86	+	1.53	5.39E-08	2.29E-06
protein modification by small protein conjugation or removal (GO:0070647)	1035	68	125.99	-	.54	5.51E-08	2.34E-06
regulation of potassium ion transport (GO:0043266)	120	42	14.61	+	2.88	6.28E-08	2.65E-06
regulation of cell adhesion (GO:0030155)	731	147	88.98	+	1.65	6.94E-08	2.93E-06
organic substance catabolic process (GO:1901575)	1769	140	215.34	-	.65	7.05E-08	2.96E-06
macromolecule modification (GO:0043412)	3211	291	390.87	-	.74	7.61E-08	3.19E-06
mesonephros development (GO:0001823)	85	34	10.35	+	3.29	7.94E-08	3.32E-06
nephron tubule development (GO:0072080)	77	32	9.37	+	3.41	9.46E-08	3.95E-06
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	100	37	12.17	+	3.04	1.08E-07	4.50E-06
muscle cell differentiation (GO:0042692)	247	66	30.07	+	2.20	1.13E-07	4.67E-06
nervous system process (GO:0050877)	1416	248	172.37	+	1.44	1.21E-07	5.01E-06
regulation of phosphorus metabolic process (GO:0051174)	1578	271	192.09	+	1.41	1.33E-07	5.47E-06
regulation of phosphate metabolic process (GO:0019220)	1578	271	192.09	+	1.41	1.33E-07	5.49E-06
modification-dependent macromolecule catabolic process (GO:0043632)	563	28	68.53	-	.41	1.36E-07	5.60E-06
kidney morphogenesis (GO:0060993)	83	33	10.10	+	3.27	1.37E-07	5.62E-06
regulation of amine transport (GO:0051952)	92	35	11.20	+	3.13	1.38E-07	5.62E-06
positive regulation of MAPK cascade (GO:0043410)	525	113	63.91	+	1.77	1.38E-07	5.63E-06
RNA splicing (GO:0008380)	409	16	49.79	-	.32	1.45E-07	5.89E-06
regulation of molecular function (GO:0065009)	3118	483	379.55	+	1.27	1.49E-07	6.03E-06
cellular catabolic process (GO:0044248)	1812	146	220.57	-	.66	1.50E-07	6.05E-06
cellular chemical homeostasis (GO:0055082)	762	150	92.76	+	1.62	1.62E-07	6.53E-06
production of molecular mediator of immune response (GO:0002440)	141	0	17.16	-	 < 0.01	1.65E-07	6.66E-06
cell cycle (GO:0007049)	1316	97	160.19	-	.61	1.74E-07	6.99E-06
ureteric bud development (GO:0001657)	80	32	9.74	+	3.29	1.89E-07	7.57E-06
cellular ion homeostasis (GO:0006873)	659	134	80.22	+	1.67	1.94E-07	7.76E-06
cell fate determination (GO:0001709)	43	23	5.23	+	4.39	1.97E-07	7.85E-06
cellular component biogenesis (GO:0044085)	2754	245	335.24	-	.73	1.98E-07	7.88E-06
cellular respiration (GO:0045333)	187	2	22.76	-	.09	2.02E-07	8.02E-06
regulation of signaling receptor activity (GO:0010469)	188	54	22.88	+	2.36	2.14E-07	8.47E-06
negative regulation of cell death (GO:0060548)	1008	187	122.70	+	1.52	2.22E-07	8.75E-06
regulation of postsynaptic membrane potential (GO:0060078)	99	36	12.05	+	2.99	2.25E-07	8.86E-06
eye morphogenesis (GO:0048592)	152	47	18.50	+	2.54	2.32E-07	9.08E-06
camera-type eye morphogenesis (GO:0048593)	125	42	15.22	+	2.76	2.31E-07	9.08E-06
mesonephric epithelium development (GO:0072163)	81	32	9.86	+	3.25	2.37E-07	9.22E-06
mesonephric tubule development (GO:0072164)	81	32	9.86	+	3.25	2.37E-07	9.24E-06
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	253	66	30.80	+	2.14	2.48E-07	9.64E-06
endocrine pancreas development (GO:0031018)	40	22	4.87	+	4.52	2.52E-07	9.75E-06
immunoglobulin production (GO:0002377)	138	0	16.80	-	 < 0.01	2.56E-07	9.91E-06
regulation of smooth muscle contraction (GO:0006940)	60	27	7.30	+	3.70	2.70E-07	1.04E-05
adult behavior (GO:0030534)	133	43	16.19	+	2.66	2.71E-07	1.04E-05
positive regulation of kinase activity (GO:0033674)	614	126	74.74	+	1.69	2.75E-07	1.06E-05
mesenchymal cell differentiation (GO:0048762)	162	49	19.72	+	2.48	2.76E-07	1.06E-05
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	301	9	36.64	-	.25	2.82E-07	1.08E-05
retina development in camera-type eye (GO:0060041)	148	46	18.02	+	2.55	2.93E-07	1.12E-05
dorsal spinal cord development (GO:0021516)	20	16	2.43	+	6.57	3.07E-07	1.17E-05
modification-dependent protein catabolic process (GO:0019941)	552	28	67.19	-	.42	3.15E-07	1.19E-05
aerobic respiration (GO:0009060)	160	1	19.48	-	.05	3.14E-07	1.19E-05
positive regulation of molecular function (GO:0044093)	1618	274	196.96	+	1.39	3.34E-07	1.26E-05
muscle organ morphogenesis (GO:0048644)	74	30	9.01	+	3.33	3.60E-07	1.35E-05
positive regulation of synaptic transmission (GO:0050806)	135	43	16.43	+	2.62	3.59E-07	1.35E-05
ribosome biogenesis (GO:0042254)	329	11	40.05	-	.27	3.73E-07	1.40E-05
ubiquitin-dependent protein catabolic process (GO:0006511)	545	28	66.34	-	.42	4.06E-07	1.52E-05
cellular macromolecule biosynthetic process (GO:0034645)	1639	131	199.51	-	.66	4.16E-07	1.55E-05
renal tubule morphogenesis (GO:0061333)	66	28	8.03	+	3.49	4.23E-07	1.56E-05
regulation of potassium ion transmembrane transport (GO:1901379)	106	37	12.90	+	2.87	4.21E-07	1.57E-05
nephron morphogenesis (GO:0072028)	66	28	8.03	+	3.49	4.23E-07	1.57E-05
RNA catabolic process (GO:0006401)	248	6	30.19	-	.20	4.43E-07	1.63E-05
regulation of cell death (GO:0010941)	1668	280	203.04	+	1.38	4.77E-07	1.76E-05
regulation of neurotransmitter receptor activity (GO:0099601)	80	31	9.74	+	3.18	5.08E-07	1.87E-05
mRNA catabolic process (GO:0006402)	215	4	26.17	-	.15	5.12E-07	1.88E-05
detection of stimulus involved in sensory perception (GO:0050906)	557	29	67.80	-	.43	5.19E-07	1.90E-05
positive regulation of intracellular signal transduction (GO:1902533)	1040	189	126.60	+	1.49	5.44E-07	1.98E-05
cell cycle process (GO:0022402)	957	65	116.49	-	.56	5.51E-07	2.01E-05
neuron fate specification (GO:0048665)	28	18	3.41	+	5.28	5.77E-07	2.10E-05
cellular response to DNA damage stimulus (GO:0006974)	793	50	96.53	-	.52	6.09E-07	2.20E-05
cellular metal ion homeostasis (GO:0006875)	561	116	68.29	+	1.70	6.09E-07	2.21E-05
positive regulation of cytosolic calcium ion concentration (GO:0007204)	283	70	34.45	+	2.03	6.23E-07	2.25E-05
mesenchyme morphogenesis (GO:0072132)	51	24	6.21	+	3.87	6.56E-07	2.36E-05
negative regulation of programmed cell death (GO:0043069)	914	170	111.26	+	1.53	6.63E-07	2.38E-05
intracellular protein transport (GO:0006886)	781	49	95.07	-	.52	6.68E-07	2.40E-05
positive regulation of secretion (GO:0051047)	317	76	38.59	+	1.97	6.72E-07	2.40E-05
nephron epithelium morphogenesis (GO:0072088)	64	27	7.79	+	3.47	7.37E-07	2.63E-05
nuclear-transcribed mRNA catabolic process (GO:0000956)	195	3	23.74	-	.13	7.60E-07	2.71E-05
cartilage development (GO:0051216)	153	46	18.62	+	2.47	8.02E-07	2.85E-05
regulation of catecholamine secretion (GO:0050433)	56	25	6.82	+	3.67	8.30E-07	2.94E-05
regulation of cellular component organization (GO:0051128)	2390	378	290.93	+	1.30	8.49E-07	3.00E-05
positive regulation of potassium ion transport (GO:0043268)	69	28	8.40	+	3.33	8.59E-07	3.02E-05
cellular response to retinoic acid (GO:0071300)	69	28	8.40	+	3.33	8.59E-07	3.02E-05
regulation of synaptic transmission, glutamatergic (GO:0051966)	69	28	8.40	+	3.33	8.59E-07	3.03E-05
ventral spinal cord development (GO:0021517)	44	22	5.36	+	4.11	8.68E-07	3.04E-05
cellular cation homeostasis (GO:0030003)	642	128	78.15	+	1.64	8.67E-07	3.04E-05
learning (GO:0007612)	146	44	17.77	+	2.48	9.41E-07	3.28E-05
embryonic skeletal system morphogenesis (GO:0048704)	95	34	11.56	+	2.94	1.00E-06	3.48E-05
regulation of protein secretion (GO:0050708)	283	69	34.45	+	2.00	1.01E-06	3.51E-05
sex differentiation (GO:0007548)	272	67	33.11	+	2.02	1.02E-06	3.54E-05
regulation of Wnt signaling pathway (GO:0030111)	377	85	45.89	+	1.85	1.06E-06	3.66E-05
somite development (GO:0061053)	79	30	9.62	+	3.12	1.08E-06	3.74E-05
negative regulation of nitrogen compound metabolic process (GO:0051172)	2453	386	298.60	+	1.29	1.10E-06	3.79E-05
protein metabolic process (GO:0019538)	4203	410	511.63	-	.80	1.10E-06	3.79E-05
stem cell differentiation (GO:0048863)	157	46	19.11	+	2.41	1.13E-06	3.86E-05
organonitrogen compound metabolic process (GO:1901564)	5246	528	638.59	-	.83	1.14E-06	3.91E-05
regulation of cellular response to growth factor stimulus (GO:0090287)	299	72	36.40	+	1.98	1.19E-06	4.06E-05
organelle fission (GO:0048285)	369	15	44.92	-	.33	1.20E-06	4.09E-05
neuromuscular process (GO:0050905)	136	42	16.56	+	2.54	1.20E-06	4.09E-05
nephron tubule morphogenesis (GO:0072078)	62	26	7.55	+	3.44	1.28E-06	4.36E-05
collagen fibril organization (GO:0030199)	103	35	12.54	+	2.79	1.32E-06	4.47E-05
response to organonitrogen compound (GO:0010243)	1014	183	123.43	+	1.48	1.33E-06	4.48E-05
catabolic process (GO:0009056)	2096	181	255.14	-	.71	1.34E-06	4.50E-05
epithelial cell differentiation (GO:0030855)	686	134	83.51	+	1.60	1.38E-06	4.63E-05
regulation of kinase activity (GO:0043549)	914	168	111.26	+	1.51	1.41E-06	4.75E-05
cardiac conduction system development (GO:0003161)	38	20	4.63	+	4.32	1.48E-06	4.94E-05
muscle tissue morphogenesis (GO:0060415)	67	27	8.16	+	3.31	1.49E-06	4.98E-05
cell population proliferation (GO:0008283)	485	102	59.04	+	1.73	1.53E-06	5.11E-05
cell-cell adhesion (GO:0098609)	515	107	62.69	+	1.71	1.55E-06	5.15E-05
chromosome organization (GO:0051276)	1064	77	129.52	-	.59	1.59E-06	5.27E-05
regulation of synapse assembly (GO:0051963)	99	34	12.05	+	2.82	1.61E-06	5.34E-05
protein-DNA complex subunit organization (GO:0071824)	296	10	36.03	-	.28	1.69E-06	5.59E-05
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	86	31	10.47	+	2.96	1.76E-06	5.81E-05
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	420	91	51.13	+	1.78	1.77E-06	5.84E-05
negative regulation of cellular metabolic process (GO:0031324)	2613	406	318.08	+	1.28	1.78E-06	5.86E-05
positive regulation of protein kinase activity (GO:0045860)	539	110	65.61	+	1.68	1.90E-06	6.24E-05
innate immune response (GO:0045087)	848	57	103.23	-	.55	1.92E-06	6.29E-05
macromolecule biosynthetic process (GO:0009059)	1680	139	204.50	-	.68	1.93E-06	6.31E-05
negative regulation of Wnt signaling pathway (GO:0030178)	219	57	26.66	+	2.14	2.01E-06	6.55E-05
appendage morphogenesis (GO:0035107)	141	42	17.16	+	2.45	2.10E-06	6.83E-05
limb morphogenesis (GO:0035108)	141	42	17.16	+	2.45	2.10E-06	6.84E-05
positive regulation of cell projection organization (GO:0031346)	353	80	42.97	+	1.86	2.27E-06	7.33E-05
immunoglobulin mediated immune response (GO:0016064)	201	4	24.47	-	.16	2.27E-06	7.35E-05
mesoderm development (GO:0007498)	121	38	14.73	+	2.58	2.29E-06	7.39E-05
RNA 3'-end processing (GO:0031123)	142	1	17.29	-	.06	2.32E-06	7.44E-05
mitochondrial gene expression (GO:0140053)	142	1	17.29	-	.06	2.32E-06	7.45E-05
mesoderm morphogenesis (GO:0048332)	69	27	8.40	+	3.21	2.33E-06	7.48E-05
negative regulation of apoptotic process (GO:0043066)	895	164	108.95	+	1.51	2.34E-06	7.50E-05
peptide metabolic process (GO:0006518)	544	30	66.22	-	.45	2.35E-06	7.50E-05
response to external stimulus (GO:0009605)	2525	393	307.36	+	1.28	2.37E-06	7.55E-05
metanephric nephron development (GO:0072210)	32	18	3.90	+	4.62	2.41E-06	7.67E-05
cellular amide metabolic process (GO:0043603)	820	55	99.82	-	.55	2.94E-06	9.33E-05
complement activation, classical pathway (GO:0006958)	161	2	19.60	-	.10	2.99E-06	9.48E-05
ribonucleoprotein complex subunit organization (GO:0071826)	196	4	23.86	-	.17	3.15E-06	9.97E-05
defense response to other organism (GO:0098542)	1038	76	126.35	-	.60	3.24E-06	1.02E-04
regulation of MAPK cascade (GO:0043408)	707	135	86.06	+	1.57	3.31E-06	1.04E-04
response to drug (GO:0042493)	394	86	47.96	+	1.79	3.51E-06	1.10E-04
protein-DNA complex assembly (GO:0065004)	256	8	31.16	-	.26	3.53E-06	1.11E-04
appendage development (GO:0048736)	175	48	21.30	+	2.25	3.58E-06	1.11E-04
positive regulation of potassium ion transmembrane transport (GO:1901381)	62	25	7.55	+	3.31	3.57E-06	1.11E-04
limb development (GO:0060173)	175	48	21.30	+	2.25	3.58E-06	1.12E-04
somitogenesis (GO:0001756)	62	25	7.55	+	3.31	3.57E-06	1.12E-04
sodium ion transmembrane transport (GO:0035725)	119	37	14.49	+	2.55	3.70E-06	1.15E-04
regulation of AMPA receptor activity (GO:2000311)	26	16	3.16	+	5.06	3.70E-06	1.15E-04
axis specification (GO:0009798)	88	31	10.71	+	2.89	3.72E-06	1.15E-04
mammary gland development (GO:0030879)	128	39	15.58	+	2.50	3.80E-06	1.17E-04
protein transport (GO:0015031)	1300	102	158.25	-	.64	3.84E-06	1.18E-04
nerve development (GO:0021675)	76	28	9.25	+	3.03	3.91E-06	1.20E-04
response to nitrogen compound (GO:1901698)	1101	193	134.02	+	1.44	3.94E-06	1.21E-04
mesoderm formation (GO:0001707)	67	26	8.16	+	3.19	4.03E-06	1.23E-04
regulation of programmed cell death (GO:0043067)	1532	254	186.49	+	1.36	4.17E-06	1.28E-04
hindbrain development (GO:0030902)	151	43	18.38	+	2.34	4.30E-06	1.31E-04
mitotic cell cycle (GO:0000278)	750	49	91.30	-	.54	4.30E-06	1.31E-04
negative regulation of transport (GO:0051051)	430	91	52.34	+	1.74	4.41E-06	1.34E-04
regulation of muscle contraction (GO:0006937)	161	45	19.60	+	2.30	4.40E-06	1.34E-04
respiratory electron transport chain (GO:0022904)	112	0	13.63	-	 < 0.01	4.51E-06	1.37E-04
positive regulation of protein modification process (GO:0031401)	1079	189	131.35	+	1.44	5.00E-06	1.51E-04
chemical synaptic transmission, postsynaptic (GO:0099565)	68	26	8.28	+	3.14	5.00E-06	1.51E-04
negative regulation of locomotion (GO:0040013)	317	72	38.59	+	1.87	5.25E-06	1.58E-04
metanephros morphogenesis (GO:0003338)	27	16	3.29	+	4.87	5.30E-06	1.59E-04
sensory perception of sound (GO:0007605)	156	44	18.99	+	2.32	5.31E-06	1.59E-04
pallium development (GO:0021543)	173	47	21.06	+	2.23	5.37E-06	1.61E-04
regulation of animal organ morphogenesis (GO:2000027)	183	49	22.28	+	2.20	5.64E-06	1.69E-04
ureteric bud morphogenesis (GO:0060675)	51	22	6.21	+	3.54	5.76E-06	1.72E-04
B cell mediated immunity (GO:0019724)	205	5	24.95	-	.20	5.84E-06	1.74E-04
columnar/cuboidal epithelial cell differentiation (GO:0002065)	78	28	9.49	+	2.95	5.84E-06	1.74E-04
ATP metabolic process (GO:0046034)	206	5	25.08	-	.20	5.92E-06	1.75E-04
mitotic cell cycle process (GO:1903047)	675	43	82.17	-	.52	5.91E-06	1.75E-04
autonomic nervous system development (GO:0048483)	47	21	5.72	+	3.67	6.09E-06	1.80E-04
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	522	105	63.54	+	1.65	6.23E-06	1.83E-04
positive regulation of secretion by cell (GO:1903532)	288	67	35.06	+	1.91	6.22E-06	1.83E-04
ribonucleoprotein complex assembly (GO:0022618)	189	4	23.01	-	.17	6.57E-06	1.93E-04
establishment of protein localization to organelle (GO:0072594)	394	19	47.96	-	.40	6.77E-06	1.98E-04
negative regulation of macromolecule metabolic process (GO:0010605)	2880	436	350.58	+	1.24	6.85E-06	2.00E-04
positive regulation of locomotion (GO:0040017)	560	111	68.17	+	1.63	6.85E-06	2.00E-04
protein modification process (GO:0036211)	2985	282	363.36	-	.78	6.90E-06	2.01E-04
viral gene expression (GO:0019080)	172	3	20.94	-	.14	6.92E-06	2.01E-04
cellular protein modification process (GO:0006464)	2985	282	363.36	-	.78	6.90E-06	2.01E-04
positive regulation of developmental growth (GO:0048639)	169	46	20.57	+	2.24	7.00E-06	2.03E-04
regulation of vesicle-mediated transport (GO:0060627)	530	106	64.52	+	1.64	7.21E-06	2.09E-04
multicellular organismal signaling (GO:0035637)	128	38	15.58	+	2.44	7.28E-06	2.10E-04
mesonephric tubule morphogenesis (GO:0072171)	52	22	6.33	+	3.48	7.36E-06	2.12E-04
G protein-coupled receptor signaling pathway (GO:0007186)	1305	220	158.86	+	1.38	7.43E-06	2.14E-04
placenta development (GO:0001890)	144	41	17.53	+	2.34	7.56E-06	2.17E-04
rRNA processing (GO:0006364)	262	9	31.89	-	.28	7.61E-06	2.18E-04
negative regulation of growth (GO:0045926)	249	60	30.31	+	1.98	7.68E-06	2.20E-04
positive regulation of cation transmembrane transport (GO:1904064)	171	46	20.82	+	2.21	8.10E-06	2.31E-04
pituitary gland development (GO:0021983)	44	20	5.36	+	3.73	8.25E-06	2.35E-04
mitotic nuclear division (GO:0140014)	201	5	24.47	-	.20	8.30E-06	2.36E-04
response to BMP (GO:0071772)	94	31	11.44	+	2.71	8.37E-06	2.37E-04
cellular response to BMP stimulus (GO:0071773)	94	31	11.44	+	2.71	8.37E-06	2.38E-04
cardiac ventricle development (GO:0003231)	123	37	14.97	+	2.47	8.41E-06	2.38E-04
cardiac septum morphogenesis (GO:0060411)	66	25	8.03	+	3.11	8.60E-06	2.43E-04
regulation of vasculature development (GO:1901342)	286	66	34.81	+	1.90	8.78E-06	2.48E-04
regulation of protein kinase activity (GO:0045859)	802	147	97.63	+	1.51	8.95E-06	2.52E-04
detection of stimulus (GO:0051606)	721	48	87.77	-	.55	9.14E-06	2.57E-04
nuclear division (GO:0000280)	339	15	41.27	-	.36	9.54E-06	2.68E-04
ossification (GO:0001503)	267	63	32.50	+	1.94	9.84E-06	2.76E-04
regulation of apoptotic process (GO:0042981)	1493	246	181.74	+	1.35	9.90E-06	2.77E-04
establishment of protein localization (GO:0045184)	1397	114	170.05	-	.67	1.00E-05	2.80E-04
regulation of cell growth (GO:0001558)	422	88	51.37	+	1.71	1.01E-05	2.80E-04
signal release (GO:0023061)	157	43	19.11	+	2.25	1.03E-05	2.87E-04
negative regulation of metabolic process (GO:0009892)	3095	463	376.75	+	1.23	1.08E-05	3.01E-04
response to hormone (GO:0009725)	819	149	99.70	+	1.49	1.09E-05	3.02E-04
proteoglycan metabolic process (GO:0006029)	85	29	10.35	+	2.80	1.09E-05	3.02E-04
embryonic appendage morphogenesis (GO:0035113)	119	36	14.49	+	2.49	1.10E-05	3.04E-04
embryonic limb morphogenesis (GO:0030326)	119	36	14.49	+	2.49	1.10E-05	3.05E-04
negative regulation of cell migration (GO:0030336)	270	63	32.87	+	1.92	1.10E-05	3.05E-04
regulation of angiogenesis (GO:0045765)	282	65	34.33	+	1.89	1.12E-05	3.08E-04
peripheral nervous system development (GO:0007422)	79	28	9.62	+	2.91	1.16E-05	3.17E-04
reproduction (GO:0000003)	1462	241	177.97	+	1.35	1.18E-05	3.24E-04
protein localization to organelle (GO:0033365)	742	50	90.32	-	.55	1.18E-05	3.24E-04
artery morphogenesis (GO:0048844)	63	24	7.67	+	3.13	1.20E-05	3.27E-04
negative regulation of response to external stimulus (GO:0032102)	559	109	68.05	+	1.60	1.23E-05	3.36E-04
regulation of body fluid levels (GO:0050878)	494	99	60.13	+	1.65	1.24E-05	3.38E-04
protein targeting (GO:0006605)	322	14	39.20	-	.36	1.28E-05	3.47E-04
muscle contraction (GO:0006936)	241	58	29.34	+	1.98	1.29E-05	3.50E-04
cellular response to lipid (GO:0071396)	481	97	58.55	+	1.66	1.30E-05	3.51E-04
neural retina development (GO:0003407)	68	25	8.28	+	3.02	1.30E-05	3.52E-04
regulation of muscle system process (GO:0090257)	231	56	28.12	+	1.99	1.35E-05	3.64E-04
response to metal ion (GO:0010038)	379	81	46.14	+	1.76	1.35E-05	3.64E-04
embryonic placenta development (GO:0001892)	81	28	9.86	+	2.84	1.39E-05	3.74E-04
roof of mouth development (GO:0060021)	87	29	10.59	+	2.74	1.44E-05	3.86E-04
cardiocyte differentiation (GO:0035051)	107	33	13.02	+	2.53	1.46E-05	3.92E-04
regulation of morphogenesis of an epithelium (GO:1905330)	64	24	7.79	+	3.08	1.48E-05	3.94E-04
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	165	3	20.09	-	.15	1.47E-05	3.94E-04
excitatory postsynaptic potential (GO:0060079)	64	24	7.79	+	3.08	1.48E-05	3.95E-04
positive regulation of epithelial cell differentiation (GO:0030858)	55	22	6.70	+	3.29	1.49E-05	3.96E-04
activation of protein kinase activity (GO:0032147)	328	72	39.93	+	1.80	1.51E-05	4.00E-04
regulation of neuron death (GO:1901214)	316	70	38.47	+	1.82	1.54E-05	4.07E-04
cellular homeostasis (GO:0019725)	895	159	108.95	+	1.46	1.55E-05	4.09E-04
mitochondrial respiratory chain complex assembly (GO:0033108)	101	0	12.29	-	 < 0.01	1.56E-05	4.12E-04
viral process (GO:0016032)	444	24	54.05	-	.44	1.63E-05	4.29E-04
central nervous system neuron development (GO:0021954)	88	29	10.71	+	2.71	1.67E-05	4.40E-04
reproductive process (GO:0022414)	1459	239	177.60	+	1.35	1.69E-05	4.45E-04
positive regulation of transferase activity (GO:0051347)	693	129	84.36	+	1.53	1.70E-05	4.46E-04
protein modification by small protein removal (GO:0070646)	295	12	35.91	-	.33	1.71E-05	4.49E-04
membrane organization (GO:0061024)	972	73	118.32	-	.62	1.80E-05	4.70E-04
negative regulation of cell motility (GO:2000146)	285	65	34.69	+	1.87	1.80E-05	4.71E-04
positive regulation of ion transmembrane transport (GO:0034767)	187	48	22.76	+	2.11	1.82E-05	4.74E-04
positive regulation of catalytic activity (GO:0043085)	1240	208	150.94	+	1.38	1.83E-05	4.77E-04
organelle assembly (GO:0070925)	796	56	96.90	-	.58	1.85E-05	4.81E-04
cellular response to organonitrogen compound (GO:0071417)	604	115	73.52	+	1.56	1.87E-05	4.86E-04
complement activation (GO:0006956)	177	4	21.55	-	.19	1.90E-05	4.92E-04
positive regulation of response to stimulus (GO:0048584)	2312	356	281.44	+	1.26	1.91E-05	4.95E-04
artery development (GO:0060840)	89	29	10.83	+	2.68	1.95E-05	5.03E-04
dopaminergic neuron differentiation (GO:0071542)	31	16	3.77	+	4.24	1.97E-05	5.06E-04
positive regulation of animal organ morphogenesis (GO:0110110)	31	16	3.77	+	4.24	1.97E-05	5.07E-04
muscle system process (GO:0003012)	288	65	35.06	+	1.85	2.00E-05	5.13E-04
regulation of axonogenesis (GO:0050770)	161	43	19.60	+	2.19	2.03E-05	5.22E-04
regulation of protein modification process (GO:0031399)	1654	266	201.34	+	1.32	2.04E-05	5.22E-04
mRNA transport (GO:0051028)	160	3	19.48	-	.15	2.05E-05	5.23E-04
memory (GO:0007613)	119	35	14.49	+	2.42	2.05E-05	5.23E-04
retina morphogenesis in camera-type eye (GO:0060042)	61	23	7.43	+	3.10	2.06E-05	5.25E-04
positive regulation of cellular component movement (GO:0051272)	558	108	67.92	+	1.59	2.07E-05	5.26E-04
localization (GO:0051179)	5831	813	709.80	+	1.15	2.09E-05	5.32E-04
positive regulation of cell motility (GO:2000147)	545	106	66.34	+	1.60	2.22E-05	5.63E-04
nephron tubule formation (GO:0072079)	17	12	2.07	+	5.80	2.29E-05	5.80E-04
regulation of cell junction assembly (GO:1901888)	202	50	24.59	+	2.03	2.34E-05	5.93E-04
regulation of heart rate (GO:0002027)	99	31	12.05	+	2.57	2.35E-05	5.93E-04
cardiac conduction (GO:0061337)	85	28	10.35	+	2.71	2.37E-05	5.96E-04
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	120	1	14.61	-	.07	2.49E-05	6.26E-04
oxidative phosphorylation (GO:0006119)	120	1	14.61	-	.07	2.49E-05	6.27E-04
protein modification by small protein conjugation (GO:0032446)	822	59	100.06	-	.59	2.51E-05	6.31E-04
positive regulation of hormone secretion (GO:0046887)	137	38	16.68	+	2.28	2.55E-05	6.38E-04
regulation of dopamine secretion (GO:0014059)	36	17	4.38	+	3.88	2.65E-05	6.63E-04
cytoplasmic translation (GO:0002181)	122	1	14.85	-	.07	2.67E-05	6.67E-04
adult locomotory behavior (GO:0008344)	74	26	9.01	+	2.89	2.68E-05	6.69E-04
positive regulation of transmembrane transport (GO:0034764)	238	56	28.97	+	1.93	2.71E-05	6.75E-04
multicellular organismal response to stress (GO:0033555)	67	24	8.16	+	2.94	2.71E-05	6.75E-04
negative regulation of secretion (GO:0051048)	165	43	20.09	+	2.14	2.79E-05	6.92E-04
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	262	60	31.89	+	1.88	2.80E-05	6.93E-04
regulation of neuronal synaptic plasticity (GO:0048168)	49	20	5.96	+	3.35	2.85E-05	7.04E-04
smooth muscle contraction (GO:0006939)	49	20	5.96	+	3.35	2.85E-05	7.05E-04
metanephric nephron morphogenesis (GO:0072273)	21	13	2.56	+	5.09	2.88E-05	7.10E-04
rRNA metabolic process (GO:0016072)	272	11	33.11	-	.33	3.00E-05	7.38E-04
negative regulation of neuron death (GO:1901215)	209	51	25.44	+	2.00	3.07E-05	7.55E-04
cell differentiation involved in kidney development (GO:0061005)	45	19	5.48	+	3.47	3.10E-05	7.62E-04
DNA conformation change (GO:0071103)	312	14	37.98	-	.37	3.11E-05	7.63E-04
cellular response to calcium ion (GO:0071277)	87	28	10.59	+	2.64	3.20E-05	7.83E-04
cellular response to nitrogen compound (GO:1901699)	664	123	80.83	+	1.52	3.22E-05	7.87E-04
calcium ion transport (GO:0006816)	244	57	29.70	+	1.92	3.28E-05	8.01E-04
activation of adenylate cyclase activity (GO:0007190)	41	18	4.99	+	3.61	3.32E-05	8.09E-04
response to inorganic substance (GO:0010035)	553	106	67.32	+	1.57	3.34E-05	8.11E-04
negative regulation of cellular component movement (GO:0051271)	293	65	35.67	+	1.82	3.34E-05	8.12E-04
mammary gland epithelium development (GO:0061180)	59	22	7.18	+	3.06	3.55E-05	8.56E-04
cardiac muscle tissue morphogenesis (GO:0055008)	59	22	7.18	+	3.06	3.55E-05	8.57E-04
ATP synthesis coupled electron transport (GO:0042773)	93	0	11.32	-	 < 0.01	3.54E-05	8.58E-04
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	93	0	11.32	-	 < 0.01	3.54E-05	8.59E-04
developmental maturation (GO:0021700)	235	55	28.61	+	1.92	3.65E-05	8.80E-04
viral transcription (GO:0019083)	116	1	14.12	-	.07	3.68E-05	8.86E-04
cardiac septum development (GO:0003279)	103	31	12.54	+	2.47	3.77E-05	9.05E-04
glial cell differentiation (GO:0010001)	173	44	21.06	+	2.09	3.96E-05	9.51E-04
metal ion transport (GO:0030001)	326	70	39.68	+	1.76	4.02E-05	9.62E-04
keratinocyte differentiation (GO:0030216)	270	11	32.87	-	.33	4.14E-05	9.90E-04
cellular component assembly (GO:0022607)	2494	235	303.59	-	.77	4.15E-05	9.90E-04
regulation of epithelial cell proliferation (GO:0050678)	340	72	41.39	+	1.74	4.17E-05	9.95E-04
spinal cord association neuron differentiation (GO:0021527)	12	10	1.46	+	6.85	4.19E-05	9.98E-04
negative regulation of neuron apoptotic process (GO:0043524)	146	39	17.77	+	2.19	4.24E-05	1.01E-03
cell junction assembly (GO:0034329)	276	62	33.60	+	1.85	4.25E-05	1.01E-03
RNA localization (GO:0006403)	212	7	25.81	-	.27	4.42E-05	1.05E-03
mesodermal cell differentiation (GO:0048333)	26	14	3.16	+	4.42	4.54E-05	1.07E-03
heart valve development (GO:0003170)	65	23	7.91	+	2.91	4.62E-05	1.09E-03
regulation of epithelial cell differentiation (GO:0030856)	147	39	17.89	+	2.18	4.65E-05	1.10E-03
synapse assembly (GO:0007416)	99	30	12.05	+	2.49	4.68E-05	1.10E-03
epithelial cell differentiation involved in kidney development (GO:0035850)	34	16	4.14	+	3.87	4.70E-05	1.10E-03
positive regulation of smooth muscle contraction (GO:0045987)	30	15	3.65	+	4.11	4.72E-05	1.11E-03
activation of immune response (GO:0002253)	530	33	64.52	-	.51	4.71E-05	1.11E-03
associative learning (GO:0008306)	79	26	9.62	+	2.70	4.77E-05	1.12E-03
keratinization (GO:0031424)	227	8	27.63	-	.29	4.91E-05	1.15E-03
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	198	48	24.10	+	1.99	4.98E-05	1.16E-03
in utero embryonic development (GO:0001701)	366	76	44.55	+	1.71	5.26E-05	1.23E-03
mitochondrial translation (GO:0032543)	112	1	13.63	-	.07	5.45E-05	1.27E-03
branching involved in ureteric bud morphogenesis (GO:0001658)	43	18	5.23	+	3.44	5.44E-05	1.27E-03
embryonic heart tube development (GO:0035050)	80	26	9.74	+	2.67	5.51E-05	1.28E-03
nuclear export (GO:0051168)	166	4	20.21	-	.20	5.54E-05	1.28E-03
protein deubiquitination (GO:0016579)	278	12	33.84	-	.35	5.60E-05	1.30E-03
sensory perception of pain (GO:0019233)	75	25	9.13	+	2.74	5.94E-05	1.37E-03
mesenchymal to epithelial transition (GO:0060231)	16	11	1.95	+	5.65	5.98E-05	1.38E-03
regulation of BMP signaling pathway (GO:0030510)	101	30	12.29	+	2.44	6.04E-05	1.39E-03
membrane invagination (GO:0010324)	148	3	18.02	-	.17	6.06E-05	1.39E-03
positive regulation of epithelial cell proliferation (GO:0050679)	194	47	23.62	+	1.99	6.33E-05	1.45E-03
phagocytosis, engulfment (GO:0006911)	132	2	16.07	-	.12	6.40E-05	1.47E-03
response to wounding (GO:0009611)	543	103	66.10	+	1.56	6.45E-05	1.48E-03
regulation of epithelial cell migration (GO:0010632)	229	53	27.88	+	1.90	6.61E-05	1.51E-03
Golgi vesicle transport (GO:0048193)	398	22	48.45	-	.45	6.75E-05	1.54E-03
positive regulation of cation channel activity (GO:2001259)	76	25	9.25	+	2.70	6.79E-05	1.55E-03
regulation of neural precursor cell proliferation (GO:2000177)	90	28	10.96	+	2.56	6.90E-05	1.56E-03
endocardial cushion development (GO:0003197)	44	18	5.36	+	3.36	6.90E-05	1.56E-03
sinoatrial node development (GO:0003163)	10	9	1.22	+	7.39	6.87E-05	1.56E-03
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	44	18	5.36	+	3.36	6.90E-05	1.56E-03
spindle organization (GO:0007051)	224	8	27.27	-	.29	6.89E-05	1.56E-03
cellular response to organic cyclic compound (GO:0071407)	511	98	62.20	+	1.58	6.87E-05	1.56E-03
sodium ion transport (GO:0006814)	176	44	21.42	+	2.05	6.86E-05	1.56E-03
chromosome segregation (GO:0007059)	286	13	34.81	-	.37	7.46E-05	1.68E-03
DNA replication (GO:0006260)	273	12	33.23	-	.36	7.49E-05	1.69E-03
regulation of postsynapse organization (GO:0099175)	91	28	11.08	+	2.53	7.57E-05	1.70E-03
regulation of cartilage development (GO:0061035)	71	24	8.64	+	2.78	7.57E-05	1.70E-03
regulation of intracellular signal transduction (GO:1902531)	1839	286	223.86	+	1.28	7.62E-05	1.71E-03
establishment of RNA localization (GO:0051236)	191	6	23.25	-	.26	7.66E-05	1.71E-03
respiratory system development (GO:0060541)	200	48	24.35	+	1.97	7.74E-05	1.73E-03
organonitrogen compound catabolic process (GO:1901565)	1091	88	132.81	-	.66	7.77E-05	1.73E-03
cellular response to metal ion (GO:0071248)	200	48	24.35	+	1.97	7.74E-05	1.73E-03
regulation of transferase activity (GO:0051338)	1033	174	125.75	+	1.38	7.77E-05	1.73E-03
cellular nitrogen compound biosynthetic process (GO:0044271)	1553	136	189.04	-	.72	7.91E-05	1.76E-03
smooth muscle cell differentiation (GO:0051145)	36	16	4.38	+	3.65	8.00E-05	1.77E-03
mitotic spindle organization (GO:0007052)	163	4	19.84	-	.20	8.02E-05	1.78E-03
detection of mechanical stimulus involved in sensory perception (GO:0050974)	36	16	4.38	+	3.65	8.00E-05	1.78E-03
adrenergic receptor signaling pathway (GO:0071875)	24	13	2.92	+	4.45	8.08E-05	1.79E-03
calcium ion transmembrane transport (GO:0070588)	190	46	23.13	+	1.99	8.12E-05	1.79E-03
developmental growth (GO:0048589)	358	74	43.58	+	1.70	8.40E-05	1.85E-03
double-strand break repair (GO:0006302)	204	7	24.83	-	.28	8.49E-05	1.87E-03
epithelial cell development (GO:0002064)	202	48	24.59	+	1.95	8.48E-05	1.87E-03
male sex differentiation (GO:0046661)	161	41	19.60	+	2.09	8.62E-05	1.89E-03
aerobic electron transport chain (GO:0019646)	88	0	10.71	-	 < 0.01	8.61E-05	1.89E-03
mRNA 3'-end processing (GO:0031124)	88	0	10.71	-	 < 0.01	8.61E-05	1.89E-03
translational initiation (GO:0006413)	143	3	17.41	-	.17	8.69E-05	1.90E-03
negative regulation of cell development (GO:0010721)	180	44	21.91	+	2.01	8.69E-05	1.90E-03
regulation of metal ion transport (GO:0010959)	262	58	31.89	+	1.82	8.73E-05	1.90E-03
ribonucleoprotein complex export from nucleus (GO:0071426)	126	2	15.34	-	.13	8.96E-05	1.95E-03
ribonucleoprotein complex localization (GO:0071166)	127	2	15.46	-	.13	9.03E-05	1.96E-03
cellular response to hormone stimulus (GO:0032870)	529	100	64.39	+	1.55	9.01E-05	1.96E-03
growth (GO:0040007)	361	74	43.94	+	1.68	9.03E-05	1.96E-03
positive regulation of synapse assembly (GO:0051965)	59	21	7.18	+	2.92	9.09E-05	1.97E-03
cyclic nucleotide metabolic process (GO:0009187)	41	17	4.99	+	3.41	9.55E-05	2.06E-03
immune system process (GO:0002376)	2903	283	353.38	-	.80	9.65E-05	2.08E-03
regulation of calcium ion transport (GO:0051924)	252	56	30.68	+	1.83	9.78E-05	2.11E-03
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	67	23	8.16	+	2.82	9.93E-05	2.14E-03
nucleobase-containing compound transport (GO:0015931)	245	10	29.82	-	.34	1.00E-04	2.16E-03
anatomical structure maturation (GO:0071695)	196	47	23.86	+	1.97	1.02E-04	2.18E-03
neuron projection fasciculation (GO:0106030)	21	12	2.56	+	4.69	1.03E-04	2.21E-03
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	21	12	2.56	+	4.69	1.03E-04	2.21E-03
axonal fasciculation (GO:0007413)	21	12	2.56	+	4.69	1.03E-04	2.22E-03
positive regulation of immune response (GO:0050778)	747	55	90.93	-	.60	1.05E-04	2.24E-03
nucleic acid transport (GO:0050657)	189	6	23.01	-	.26	1.08E-04	2.31E-03
RNA transport (GO:0050658)	189	6	23.01	-	.26	1.08E-04	2.31E-03
genitalia development (GO:0048806)	46	18	5.60	+	3.21	1.09E-04	2.31E-03
positive regulation of peptide secretion (GO:0002793)	110	31	13.39	+	2.32	1.10E-04	2.34E-03
import into cell (GO:0098657)	176	43	21.42	+	2.01	1.11E-04	2.35E-03
tRNA metabolic process (GO:0006399)	190	6	23.13	-	.26	1.11E-04	2.35E-03
cardiac atrium morphogenesis (GO:0003209)	29	14	3.53	+	3.97	1.12E-04	2.37E-03
regulation of osteoblast differentiation (GO:0045667)	120	33	14.61	+	2.26	1.14E-04	2.40E-03
regulation of morphogenesis of a branching structure (GO:0060688)	51	19	6.21	+	3.06	1.19E-04	2.52E-03
cranial nerve development (GO:0021545)	51	19	6.21	+	3.06	1.19E-04	2.52E-03
determination of bilateral symmetry (GO:0009855)	130	35	15.82	+	2.21	1.22E-04	2.56E-03
oligodendrocyte differentiation (GO:0048709)	69	23	8.40	+	2.74	1.23E-04	2.58E-03
bone development (GO:0060348)	189	45	23.01	+	1.96	1.24E-04	2.61E-03
plasma membrane invagination (GO:0099024)	141	3	17.16	-	.17	1.26E-04	2.64E-03
regulation of neurotransmitter transport (GO:0051588)	105	30	12.78	+	2.35	1.27E-04	2.66E-03
epithelial to mesenchymal transition (GO:0001837)	75	24	9.13	+	2.63	1.28E-04	2.67E-03
specification of symmetry (GO:0009799)	131	35	15.95	+	2.19	1.28E-04	2.68E-03
cell differentiation involved in metanephros development (GO:0072202)	18	11	2.19	+	5.02	1.29E-04	2.69E-03
electron transport chain (GO:0022900)	170	5	20.69	-	.24	1.31E-04	2.74E-03
protein-containing complex disassembly (GO:0032984)	228	9	27.75	-	.32	1.32E-04	2.75E-03
ameboidal-type cell migration (GO:0001667)	181	44	22.03	+	2.00	1.32E-04	2.75E-03
RNA modification (GO:0009451)	172	5	20.94	-	.24	1.33E-04	2.76E-03
intracellular signal transduction (GO:0035556)	1677	262	204.14	+	1.28	1.34E-04	2.76E-03
positive regulation of cell migration (GO:0030335)	520	98	63.30	+	1.55	1.33E-04	2.77E-03
determination of heart left/right asymmetry (GO:0061371)	70	23	8.52	+	2.70	1.39E-04	2.86E-03
regulation of ossification (GO:0030278)	115	32	14.00	+	2.29	1.40E-04	2.90E-03
hindlimb morphogenesis (GO:0035137)	34	15	4.14	+	3.62	1.42E-04	2.92E-03
positive regulation of axonogenesis (GO:0050772)	84	26	10.23	+	2.54	1.43E-04	2.94E-03
cartilage condensation (GO:0001502)	22	12	2.68	+	4.48	1.44E-04	2.96E-03
humoral immune response (GO:0006959)	386	22	46.99	-	.47	1.46E-04	2.99E-03
cochlea development (GO:0090102)	52	19	6.33	+	3.00	1.47E-04	3.01E-03
female sex differentiation (GO:0046660)	107	30	13.02	+	2.30	1.54E-04	3.16E-03
regulation of canonical Wnt signaling pathway (GO:0060828)	298	63	36.28	+	1.74	1.55E-04	3.17E-03
muscle cell fate commitment (GO:0042693)	15	10	1.83	+	5.48	1.56E-04	3.19E-03
skeletal muscle organ development (GO:0060538)	134	35	16.31	+	2.15	1.57E-04	3.21E-03
morphogenesis of embryonic epithelium (GO:0016331)	145	37	17.65	+	2.10	1.65E-04	3.37E-03
second-messenger-mediated signaling (GO:0019932)	221	50	26.90	+	1.86	1.67E-04	3.39E-03
negative regulation of Notch signaling pathway (GO:0045746)	39	16	4.75	+	3.37	1.68E-04	3.39E-03
negative regulation of immune system process (GO:0002683)	597	109	72.67	+	1.50	1.67E-04	3.39E-03
development of primary sexual characteristics (GO:0045137)	221	50	26.90	+	1.86	1.67E-04	3.39E-03
glutamate receptor signaling pathway (GO:0007215)	48	18	5.84	+	3.08	1.67E-04	3.39E-03
amide biosynthetic process (GO:0043604)	537	36	65.37	-	.55	1.75E-04	3.54E-03
regulation of neuron apoptotic process (GO:0043523)	210	48	25.56	+	1.88	1.75E-04	3.54E-03
double-strand break repair via homologous recombination (GO:0000724)	101	1	12.29	-	.08	1.77E-04	3.57E-03
regulation of bone remodeling (GO:0046850)	53	19	6.45	+	2.94	1.79E-04	3.60E-03
regulation of fat cell differentiation (GO:0045598)	128	34	15.58	+	2.18	1.79E-04	3.60E-03
regulation of behavior (GO:0050795)	72	23	8.76	+	2.62	1.82E-04	3.65E-03
endocardial cushion morphogenesis (GO:0003203)	35	15	4.26	+	3.52	1.82E-04	3.65E-03
DNA recombination (GO:0006310)	225	9	27.39	-	.33	1.83E-04	3.66E-03
negative regulation of platelet activation (GO:0010544)	19	11	2.31	+	4.76	1.84E-04	3.68E-03
recombinational repair (GO:0000725)	103	1	12.54	-	.08	1.85E-04	3.70E-03
DNA-templated transcription, termination (GO:0006353)	79	0	9.62	-	 < 0.01	1.87E-04	3.74E-03
negative regulation of blood pressure (GO:0045776)	44	17	5.36	+	3.17	1.89E-04	3.77E-03
regulation of complement activation (GO:0030449)	118	2	14.36	-	.14	1.90E-04	3.79E-03
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	147	37	17.89	+	2.07	1.91E-04	3.79E-03
tube formation (GO:0035148)	147	37	17.89	+	2.07	1.91E-04	3.79E-03
striated muscle cell differentiation (GO:0051146)	191	45	23.25	+	1.94	1.93E-04	3.82E-03
neurotransmitter metabolic process (GO:0042133)	31	14	3.77	+	3.71	1.94E-04	3.84E-03
hypothalamus development (GO:0021854)	23	12	2.80	+	4.29	1.98E-04	3.91E-03
cell aggregation (GO:0098743)	23	12	2.80	+	4.29	1.98E-04	3.91E-03
outflow tract morphogenesis (GO:0003151)	67	22	8.16	+	2.70	1.99E-04	3.92E-03
detection of stimulus involved in sensory perception of pain (GO:0062149)	27	13	3.29	+	3.96	2.00E-04	3.93E-03
negative regulation of amine transport (GO:0051953)	27	13	3.29	+	3.96	2.00E-04	3.93E-03
regulation of telomere maintenance (GO:0032204)	81	0	9.86	-	 < 0.01	2.00E-04	3.94E-03
odontogenesis (GO:0042476)	120	32	14.61	+	2.19	2.06E-04	4.04E-03
hippocampus development (GO:0021766)	81	25	9.86	+	2.54	2.06E-04	4.04E-03
negative regulation of nervous system development (GO:0051961)	148	37	18.02	+	2.05	2.07E-04	4.04E-03
regulation of endothelial cell migration (GO:0010594)	170	41	20.69	+	1.98	2.06E-04	4.04E-03
positive regulation of blood pressure (GO:0045777)	40	16	4.87	+	3.29	2.11E-04	4.13E-03
antigen processing and presentation of peptide antigen (GO:0048002)	193	7	23.49	-	.30	2.23E-04	4.36E-03
DNA-dependent DNA replication (GO:0006261)	195	7	23.74	-	.29	2.29E-04	4.45E-03
negative regulation of secretion by cell (GO:1903531)	142	36	17.29	+	2.08	2.29E-04	4.46E-03
forebrain cell migration (GO:0021885)	62	21	7.55	+	2.78	2.31E-04	4.49E-03
regulation of potassium ion transmembrane transporter activity (GO:1901016)	62	21	7.55	+	2.78	2.31E-04	4.49E-03
SMAD protein signal transduction (GO:0060395)	62	21	7.55	+	2.78	2.31E-04	4.50E-03
cardiac atrium development (GO:0003230)	36	15	4.38	+	3.42	2.32E-04	4.50E-03
glandular epithelial cell differentiation (GO:0002067)	45	17	5.48	+	3.10	2.34E-04	4.53E-03
regulation of gliogenesis (GO:0014013)	98	28	11.93	+	2.35	2.34E-04	4.53E-03
midbrain development (GO:0030901)	89	26	10.83	+	2.40	2.37E-04	4.56E-03
response to calcium ion (GO:0051592)	153	38	18.62	+	2.04	2.37E-04	4.56E-03
epithelial tube formation (GO:0072175)	132	34	16.07	+	2.12	2.36E-04	4.56E-03
regulation of sodium ion transport (GO:0002028)	89	26	10.83	+	2.40	2.37E-04	4.57E-03
regulation of glial cell differentiation (GO:0045685)	74	23	9.01	+	2.55	2.42E-04	4.65E-03
cell maturation (GO:0048469)	154	38	18.75	+	2.03	2.49E-04	4.78E-03
determination of left/right symmetry (GO:0007368)	125	33	15.22	+	2.17	2.50E-04	4.80E-03
positive regulation of cartilage development (GO:0061036)	32	14	3.90	+	3.59	2.51E-04	4.80E-03
negative regulation of canonical Wnt signaling pathway (GO:0090090)	187	44	22.76	+	1.93	2.53E-04	4.83E-03
regulation of vasoconstriction (GO:0019229)	63	21	7.67	+	2.74	2.56E-04	4.88E-03
RNA phosphodiester bond hydrolysis (GO:0090501)	164	5	19.96	-	.25	2.61E-04	4.97E-03
response to estradiol (GO:0032355)	144	36	17.53	+	2.05	2.62E-04	4.99E-03
translational termination (GO:0006415)	97	1	11.81	-	.08	2.62E-04	4.99E-03
regulation of cardiocyte differentiation (GO:1905207)	28	13	3.41	+	3.81	2.64E-04	4.99E-03
sensory perception of temperature stimulus (GO:0050951)	28	13	3.41	+	3.81	2.64E-04	5.00E-03
heart valve morphogenesis (GO:0003179)	55	19	6.70	+	2.84	2.64E-04	5.00E-03
positive regulation of neural precursor cell proliferation (GO:2000179)	55	19	6.70	+	2.84	2.64E-04	5.01E-03
canonical Wnt signaling pathway (GO:0060070)	84	25	10.23	+	2.44	2.69E-04	5.08E-03
renal vesicle morphogenesis (GO:0072077)	13	9	1.58	+	5.69	2.73E-04	5.16E-03
immune response-activating signal transduction (GO:0002757)	455	29	55.39	-	.52	2.75E-04	5.18E-03
immune response-activating cell surface receptor signaling pathway (GO:0002429)	455	29	55.39	-	.52	2.75E-04	5.19E-03
regulation of systemic arterial blood pressure (GO:0003073)	100	28	12.17	+	2.30	2.77E-04	5.20E-03
positive regulation of gliogenesis (GO:0014015)	64	21	7.79	+	2.70	2.86E-04	5.38E-03
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	178	6	21.67	-	.28	2.93E-04	5.50E-03
immune response-regulating signaling pathway (GO:0002764)	495	33	60.26	-	.55	2.93E-04	5.50E-03
aortic valve development (GO:0003176)	37	15	4.50	+	3.33	2.94E-04	5.51E-03
cardiac ventricle morphogenesis (GO:0003208)	70	22	8.52	+	2.58	2.97E-04	5.56E-03
proteolysis (GO:0006508)	1306	114	158.98	-	.72	2.98E-04	5.57E-03
positive regulation of cellular component organization (GO:0051130)	1161	188	141.33	+	1.33	3.00E-04	5.59E-03
anterior/posterior axon guidance (GO:0033564)	7	7	.85	+	8.21	3.02E-04	5.63E-03
organic substance biosynthetic process (GO:1901576)	2803	277	341.21	-	.81	3.04E-04	5.66E-03
positive regulation of cellular protein metabolic process (GO:0032270)	1474	231	179.43	+	1.29	3.11E-04	5.79E-03
regulation of receptor internalization (GO:0002090)	58	20	7.06	+	2.83	3.14E-04	5.83E-03
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	269	13	32.74	-	.40	3.21E-04	5.95E-03
regulation of synaptic transmission, GABAergic (GO:0032228)	33	14	4.02	+	3.49	3.22E-04	5.95E-03
proximal/distal pattern formation (GO:0009954)	33	14	4.02	+	3.49	3.22E-04	5.96E-03
response to amphetamine (GO:0001975)	33	14	4.02	+	3.49	3.22E-04	5.97E-03
heart looping (GO:0001947)	65	21	7.91	+	2.65	3.23E-04	5.97E-03
regulation of odontogenesis (GO:0042481)	17	10	2.07	+	4.83	3.28E-04	6.05E-03
protein ubiquitination (GO:0016567)	746	57	90.81	-	.63	3.29E-04	6.05E-03
ureter development (GO:0072189)	17	10	2.07	+	4.83	3.28E-04	6.06E-03
positive regulation of neuron projection development (GO:0010976)	161	39	19.60	+	1.99	3.31E-04	6.09E-03
response to mechanical stimulus (GO:0009612)	220	49	26.78	+	1.83	3.36E-04	6.16E-03
positive regulation of cell junction assembly (GO:1901890)	102	28	12.42	+	2.26	3.36E-04	6.17E-03
telencephalon cell migration (GO:0022029)	59	20	7.18	+	2.78	3.38E-04	6.19E-03
regulation of extent of cell growth (GO:0061387)	112	30	13.63	+	2.20	3.38E-04	6.19E-03
embryonic heart tube morphogenesis (GO:0003143)	71	22	8.64	+	2.55	3.43E-04	6.26E-03
negative regulation of inflammatory response (GO:0050728)	320	65	38.95	+	1.67	3.47E-04	6.33E-03
nitrogen compound transport (GO:0071705)	1708	157	207.91	-	.76	3.48E-04	6.34E-03
sympathetic nervous system development (GO:0048485)	21	11	2.56	+	4.30	3.54E-04	6.43E-03
regulation of platelet aggregation (GO:0090330)	21	11	2.56	+	4.30	3.54E-04	6.44E-03
metanephric epithelium development (GO:0072207)	21	11	2.56	+	4.30	3.54E-04	6.45E-03
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	492	33	59.89	-	.55	3.67E-04	6.65E-03
regulation of chondrocyte differentiation (GO:0032330)	52	18	6.33	+	2.84	3.71E-04	6.72E-03
gliogenesis (GO:0042063)	223	49	27.15	+	1.81	3.71E-04	6.72E-03
glomerulus development (GO:0032835)	52	18	6.33	+	2.84	3.71E-04	6.72E-03
cardiac muscle cell differentiation (GO:0055007)	81	24	9.86	+	2.43	3.82E-04	6.91E-03
endothelium development (GO:0003158)	97	27	11.81	+	2.29	3.90E-04	7.02E-03
bone morphogenesis (GO:0060349)	97	27	11.81	+	2.29	3.90E-04	7.03E-03
regulation of Notch signaling pathway (GO:0008593)	106	29	12.90	+	2.25	3.97E-04	7.14E-03
response to alcohol (GO:0097305)	253	54	30.80	+	1.75	3.99E-04	7.18E-03
positive regulation of muscle contraction (GO:0045933)	43	16	5.23	+	3.06	4.06E-04	7.27E-03
GABAergic neuron differentiation (GO:0097154)	14	9	1.70	+	5.28	4.06E-04	7.27E-03
renal vesicle development (GO:0072087)	14	9	1.70	+	5.28	4.06E-04	7.28E-03
negative regulation of homotypic cell-cell adhesion (GO:0034111)	14	9	1.70	+	5.28	4.06E-04	7.29E-03
response to peptide (GO:1901652)	488	90	59.40	+	1.52	4.13E-04	7.37E-03
regulation of endothelial cell proliferation (GO:0001936)	135	34	16.43	+	2.07	4.12E-04	7.37E-03
positive regulation of peptide hormone secretion (GO:0090277)	107	29	13.02	+	2.23	4.17E-04	7.43E-03
nuclear transport (GO:0051169)	264	13	32.14	-	.40	4.17E-04	7.44E-03
antigen processing and presentation of exogenous antigen (GO:0019884)	186	7	22.64	-	.31	4.23E-04	7.53E-03
developmental growth involved in morphogenesis (GO:0060560)	115	30	14.00	+	2.14	4.36E-04	7.76E-03
regulation of neurotransmitter secretion (GO:0046928)	91	26	11.08	+	2.35	4.46E-04	7.90E-03
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	30	13	3.65	+	3.56	4.45E-04	7.90E-03
antigen processing and presentation (GO:0019882)	225	10	27.39	-	.37	4.46E-04	7.91E-03
neurotransmitter biosynthetic process (GO:0042136)	18	10	2.19	+	4.56	4.61E-04	8.14E-03
spinal cord patterning (GO:0021511)	18	10	2.19	+	4.56	4.61E-04	8.15E-03
chondroitin sulfate metabolic process (GO:0030204)	39	15	4.75	+	3.16	4.61E-04	8.15E-03
regulation of heart rate by cardiac conduction (GO:0086091)	39	15	4.75	+	3.16	4.61E-04	8.16E-03
regulation of animal organ formation (GO:0003156)	26	12	3.16	+	3.79	4.71E-04	8.29E-03
positive regulation of heart rate (GO:0010460)	26	12	3.16	+	3.79	4.71E-04	8.30E-03
action potential (GO:0001508)	92	26	11.20	+	2.32	4.73E-04	8.32E-03
metanephric renal vesicle morphogenesis (GO:0072283)	11	8	1.34	+	5.97	4.77E-04	8.38E-03
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	207	46	25.20	+	1.83	4.83E-04	8.47E-03
positive regulation of vasculature development (GO:1904018)	160	38	19.48	+	1.95	4.91E-04	8.59E-03
positive regulation of angiogenesis (GO:0045766)	160	38	19.48	+	1.95	4.91E-04	8.60E-03
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	44	16	5.36	+	2.99	4.99E-04	8.71E-03
negative regulation of peptide hormone secretion (GO:0090278)	44	16	5.36	+	2.99	4.99E-04	8.72E-03
nucleosome organization (GO:0034728)	156	5	18.99	-	.26	5.06E-04	8.83E-03
positive regulation of ion transmembrane transporter activity (GO:0032414)	110	29	13.39	+	2.17	5.10E-04	8.89E-03
embryonic eye morphogenesis (GO:0048048)	35	14	4.26	+	3.29	5.17E-04	9.00E-03
positive regulation of gene expression (GO:0010628)	1169	187	142.30	+	1.31	5.20E-04	9.03E-03
gland morphogenesis (GO:0022612)	100	27	12.17	+	2.22	5.21E-04	9.04E-03
response to amine (GO:0014075)	49	17	5.96	+	2.85	5.24E-04	9.08E-03
lung development (GO:0030324)	173	40	21.06	+	1.90	5.29E-04	9.17E-03
response to extracellular stimulus (GO:0009991)	531	96	64.64	+	1.49	5.34E-04	9.25E-03
translational elongation (GO:0006414)	127	3	15.46	-	.19	5.41E-04	9.36E-03
lymphocyte mediated immunity (GO:0002449)	259	13	31.53	-	.41	5.46E-04	9.43E-03
dendrite development (GO:0016358)	111	29	13.51	+	2.15	5.54E-04	9.56E-03
nucleocytoplasmic transport (GO:0006913)	261	13	31.77	-	.41	5.59E-04	9.63E-03
fat cell differentiation (GO:0045444)	103	28	12.54	+	2.23	5.60E-04	9.65E-03
regulation of chemotaxis (GO:0050920)	226	49	27.51	+	1.78	5.70E-04	9.81E-03
positive regulation of cell adhesion (GO:0045785)	438	82	53.32	+	1.54	5.84E-04	1.00E-02
nucleobase-containing compound catabolic process (GO:0034655)	373	23	45.40	-	.51	5.89E-04	1.01E-02
regulation of cell-cell adhesion (GO:0022407)	439	82	53.44	+	1.53	5.92E-04	1.02E-02
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	184	7	22.40	-	.31	5.98E-04	1.02E-02
cellular response to inorganic substance (GO:0071241)	228	49	27.75	+	1.77	6.03E-04	1.03E-02
metencephalon development (GO:0022037)	112	29	13.63	+	2.13	6.05E-04	1.03E-02
regulation of cell cycle G2/M phase transition (GO:1902749)	222	10	27.02	-	.37	6.05E-04	1.03E-02
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	110	2	13.39	-	.15	6.09E-04	1.04E-02
negative regulation of peptide secretion (GO:0002792)	45	16	5.48	+	2.92	6.09E-04	1.04E-02
mRNA export from nucleus (GO:0006406)	110	2	13.39	-	.15	6.09E-04	1.04E-02
embryonic hindlimb morphogenesis (GO:0035116)	27	12	3.29	+	3.65	6.14E-04	1.04E-02
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	197	8	23.98	-	.33	6.14E-04	1.04E-02
detection of temperature stimulus (GO:0016048)	27	12	3.29	+	3.65	6.14E-04	1.04E-02
ionotropic glutamate receptor signaling pathway (GO:0035235)	27	12	3.29	+	3.65	6.14E-04	1.04E-02
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	27	12	3.29	+	3.65	6.14E-04	1.04E-02
skeletal muscle tissue development (GO:0007519)	123	31	14.97	+	2.07	6.24E-04	1.05E-02
neuromuscular process controlling balance (GO:0050885)	50	17	6.09	+	2.79	6.32E-04	1.07E-02
response to abiotic stimulus (GO:0009628)	1175	187	143.03	+	1.31	6.32E-04	1.07E-02
positive regulation of stem cell differentiation (GO:2000738)	19	10	2.31	+	4.32	6.36E-04	1.07E-02
forebrain regionalization (GO:0021871)	23	11	2.80	+	3.93	6.40E-04	1.07E-02
male genitalia development (GO:0030539)	23	11	2.80	+	3.93	6.40E-04	1.07E-02
enteroendocrine cell differentiation (GO:0035883)	23	11	2.80	+	3.93	6.40E-04	1.08E-02
regulation of muscle cell differentiation (GO:0051147)	145	35	17.65	+	1.98	6.40E-04	1.08E-02
regulation of platelet activation (GO:0010543)	36	14	4.38	+	3.19	6.47E-04	1.08E-02
neuron maturation (GO:0042551)	36	14	4.38	+	3.19	6.47E-04	1.08E-02
response to corticosteroid (GO:0031960)	168	39	20.45	+	1.91	6.53E-04	1.09E-02
hormone secretion (GO:0046879)	73	22	8.89	+	2.48	6.64E-04	1.11E-02
positive regulation of protein tyrosine kinase activity (GO:0061098)	59	19	7.18	+	2.65	6.68E-04	1.11E-02
sprouting angiogenesis (GO:0002040)	59	19	7.18	+	2.65	6.68E-04	1.11E-02
neural crest cell differentiation (GO:0014033)	89	25	10.83	+	2.31	6.73E-04	1.12E-02
embryonic epithelial tube formation (GO:0001838)	124	31	15.09	+	2.05	6.74E-04	1.12E-02
positive regulation of protein metabolic process (GO:0051247)	1562	240	190.14	+	1.26	6.83E-04	1.14E-02
cellular response to topologically incorrect protein (GO:0035967)	152	5	18.50	-	.27	7.03E-04	1.17E-02
semi-lunar valve development (GO:1905314)	41	15	4.99	+	3.01	7.03E-04	1.17E-02
cardiac cell fate commitment (GO:0060911)	12	8	1.46	+	5.48	7.20E-04	1.19E-02
negative regulation of platelet aggregation (GO:0090331)	12	8	1.46	+	5.48	7.20E-04	1.19E-02
aortic valve morphogenesis (GO:0003180)	32	13	3.90	+	3.34	7.22E-04	1.19E-02
regulation of kidney development (GO:0090183)	32	13	3.90	+	3.34	7.22E-04	1.19E-02
energy derivation by oxidation of organic compounds (GO:0015980)	256	13	31.16	-	.42	7.25E-04	1.20E-02
anterior/posterior axis specification (GO:0009948)	53	18	6.45	+	2.79	7.31E-04	1.20E-02
response to nicotine (GO:0035094)	46	16	5.60	+	2.86	7.39E-04	1.21E-02
negative chemotaxis (GO:0050919)	46	16	5.60	+	2.86	7.39E-04	1.22E-02
regulation of bone resorption (GO:0045124)	46	16	5.60	+	2.86	7.39E-04	1.22E-02
signal release from synapse (GO:0099643)	81	23	9.86	+	2.33	7.47E-04	1.22E-02
neurotransmitter secretion (GO:0007269)	81	23	9.86	+	2.33	7.47E-04	1.23E-02
cellular nitrogen compound catabolic process (GO:0044270)	423	28	51.49	-	.54	7.47E-04	1.23E-02
proteoglycan biosynthetic process (GO:0030166)	60	19	7.30	+	2.60	7.54E-04	1.23E-02
establishment of localization in cell (GO:0051649)	2335	229	284.24	-	.81	7.55E-04	1.23E-02
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	60	19	7.30	+	2.60	7.54E-04	1.23E-02
multicellular organismal homeostasis (GO:0048871)	364	70	44.31	+	1.58	7.58E-04	1.24E-02
negative regulation of ion transport (GO:0043271)	148	35	18.02	+	1.94	7.63E-04	1.24E-02
osteoblast differentiation (GO:0001649)	129	32	15.70	+	2.04	7.85E-04	1.28E-02
protein acylation (GO:0043543)	178	7	21.67	-	.32	7.90E-04	1.28E-02
RNA export from nucleus (GO:0006405)	124	3	15.09	-	.20	7.91E-04	1.29E-02
regulation of chromosome organization (GO:0033044)	290	16	35.30	-	.45	7.97E-04	1.29E-02
regulation of endocrine process (GO:0044060)	37	14	4.50	+	3.11	8.04E-04	1.30E-02
response to topologically incorrect protein (GO:0035966)	191	8	23.25	-	.34	8.06E-04	1.31E-02
excitatory chemical synaptic transmission (GO:0098976)	9	7	1.10	+	6.39	8.27E-04	1.34E-02
sinoatrial node cell differentiation (GO:0060921)	6	6	.73	+	8.21	8.39E-04	1.35E-02
negative regulation of cellular response to growth factor stimulus (GO:0090288)	109	28	13.27	+	2.11	8.38E-04	1.35E-02
metanephric tubule formation (GO:0072174)	6	6	.73	+	8.21	8.39E-04	1.36E-02
regulation of organ growth (GO:0046620)	92	25	11.20	+	2.23	8.43E-04	1.36E-02
negative regulation of leukocyte migration (GO:0002686)	42	15	5.11	+	2.93	8.59E-04	1.38E-02
trabecula morphogenesis (GO:0061383)	42	15	5.11	+	2.93	8.59E-04	1.38E-02
positive regulation of chondrocyte differentiation (GO:0032332)	20	10	2.43	+	4.11	8.62E-04	1.38E-02
positive regulation of glial cell differentiation (GO:0045687)	42	15	5.11	+	2.93	8.59E-04	1.38E-02
positive regulation of growth (GO:0045927)	257	53	31.28	+	1.69	8.59E-04	1.38E-02
uterus development (GO:0060065)	20	10	2.43	+	4.11	8.62E-04	1.38E-02
ventricular cardiac muscle tissue development (GO:0003229)	55	18	6.70	+	2.69	8.67E-04	1.39E-02
mitochondrial translational elongation (GO:0070125)	88	1	10.71	-	.09	8.72E-04	1.39E-02
tRNA processing (GO:0008033)	134	4	16.31	-	.25	8.77E-04	1.40E-02
respiratory tube development (GO:0030323)	177	40	21.55	+	1.86	8.81E-04	1.41E-02
gonad development (GO:0008406)	215	46	26.17	+	1.76	8.88E-04	1.41E-02
negative regulation of cell growth (GO:0030308)	190	42	23.13	+	1.82	9.02E-04	1.44E-02
inorganic cation import across plasma membrane (GO:0098659)	85	24	10.35	+	2.32	9.09E-04	1.44E-02
inorganic ion import across plasma membrane (GO:0099587)	85	24	10.35	+	2.32	9.09E-04	1.44E-02
mitochondrial translational termination (GO:0070126)	89	1	10.83	-	.09	9.08E-04	1.44E-02
regulation of presynapse organization (GO:0099174)	33	13	4.02	+	3.24	9.08E-04	1.44E-02
regulation of presynapse assembly (GO:1905606)	33	13	4.02	+	3.24	9.08E-04	1.44E-02
negative regulation of neurogenesis (GO:0050768)	143	34	17.41	+	1.95	9.19E-04	1.45E-02
positive regulation of endothelial cell proliferation (GO:0001938)	93	25	11.32	+	2.21	9.22E-04	1.46E-02
positive regulation of transporter activity (GO:0032411)	121	30	14.73	+	2.04	9.27E-04	1.46E-02
positive regulation of lipid metabolic process (GO:0045834)	155	36	18.87	+	1.91	9.46E-04	1.49E-02
ventricular septum development (GO:0003281)	70	21	8.52	+	2.46	9.59E-04	1.51E-02
neural precursor cell proliferation (GO:0061351)	70	21	8.52	+	2.46	9.59E-04	1.51E-02
response to cocaine (GO:0042220)	56	18	6.82	+	2.64	9.64E-04	1.52E-02
positive regulation of phospholipase activity (GO:0010518)	62	19	7.55	+	2.52	9.79E-04	1.54E-02
negative regulation of synaptic transmission (GO:0050805)	62	19	7.55	+	2.52	9.79E-04	1.54E-02
sister chromatid segregation (GO:0000819)	149	5	18.14	-	.28	9.88E-04	1.55E-02
positive regulation of heart contraction (GO:0045823)	38	14	4.63	+	3.03	9.91E-04	1.55E-02
positive regulation of amine transport (GO:0051954)	38	14	4.63	+	3.03	9.91E-04	1.55E-02
spinal cord motor neuron differentiation (GO:0021522)	29	12	3.53	+	3.40	1.01E-03	1.58E-02
regulation of homotypic cell-cell adhesion (GO:0034110)	29	12	3.53	+	3.40	1.01E-03	1.58E-02
mitochondrial respiratory chain complex I assembly (GO:0032981)	66	0	8.03	-	 < 0.01	1.03E-03	1.60E-02
NADH dehydrogenase complex assembly (GO:0010257)	66	0	8.03	-	 < 0.01	1.03E-03	1.60E-02
potassium ion import across plasma membrane (GO:1990573)	43	15	5.23	+	2.87	1.04E-03	1.63E-02
mesodermal cell fate commitment (GO:0001710)	13	8	1.58	+	5.06	1.05E-03	1.63E-02
BMP signaling pathway (GO:0030509)	78	22	9.49	+	2.32	1.05E-03	1.64E-02
ventral spinal cord interneuron differentiation (GO:0021514)	13	8	1.58	+	5.06	1.05E-03	1.64E-02
glial cell fate commitment (GO:0021781)	13	8	1.58	+	5.06	1.05E-03	1.64E-02
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	212	10	25.81	-	.39	1.06E-03	1.64E-02
regulation of protein localization (GO:0032880)	894	146	108.83	+	1.34	1.07E-03	1.66E-02
multi-multicellular organism process (GO:0044706)	210	45	25.56	+	1.76	1.08E-03	1.68E-02
secondary palate development (GO:0062009)	25	11	3.04	+	3.61	1.10E-03	1.69E-02
detection of external stimulus (GO:0009581)	137	33	16.68	+	1.98	1.10E-03	1.70E-02
response to steroid hormone (GO:0048545)	285	57	34.69	+	1.64	1.11E-03	1.71E-02
DNA packaging (GO:0006323)	202	9	24.59	-	.37	1.12E-03	1.72E-02
regulation of fatty acid oxidation (GO:0046320)	34	13	4.14	+	3.14	1.13E-03	1.74E-02
circadian rhythm (GO:0007623)	138	33	16.80	+	1.96	1.14E-03	1.75E-02
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	17	9	2.07	+	4.35	1.15E-03	1.76E-02
type B pancreatic cell differentiation (GO:0003309)	21	10	2.56	+	3.91	1.15E-03	1.76E-02
retinal ganglion cell axon guidance (GO:0031290)	17	9	2.07	+	4.35	1.15E-03	1.76E-02
regulation of collateral sprouting (GO:0048670)	21	10	2.56	+	3.91	1.15E-03	1.76E-02
post-anal tail morphogenesis (GO:0036342)	17	9	2.07	+	4.35	1.15E-03	1.76E-02
spinal cord dorsal/ventral patterning (GO:0021513)	17	9	2.07	+	4.35	1.15E-03	1.76E-02
myelination (GO:0042552)	106	27	12.90	+	2.09	1.16E-03	1.77E-02
regulation of protein serine/threonine kinase activity (GO:0071900)	493	88	60.01	+	1.47	1.16E-03	1.78E-02
heterocycle catabolic process (GO:0046700)	417	28	50.76	-	.55	1.17E-03	1.78E-02
positive regulation of epithelial cell migration (GO:0010634)	150	35	18.26	+	1.92	1.17E-03	1.79E-02
response to alkaloid (GO:0043279)	117	29	14.24	+	2.04	1.19E-03	1.80E-02
detection of abiotic stimulus (GO:0009582)	139	33	16.92	+	1.95	1.19E-03	1.81E-02
proteasomal protein catabolic process (GO:0010498)	361	23	43.94	-	.52	1.20E-03	1.82E-02
calcium ion transport into cytosol (GO:0060402)	73	21	8.89	+	2.36	1.22E-03	1.85E-02
cotranslational protein targeting to membrane (GO:0006613)	101	2	12.29	-	.16	1.22E-03	1.86E-02
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	140	33	17.04	+	1.94	1.25E-03	1.89E-02
membrane depolarization (GO:0051899)	52	17	6.33	+	2.69	1.26E-03	1.91E-02
digestive tract morphogenesis (GO:0048546)	44	15	5.36	+	2.80	1.26E-03	1.91E-02
substrate-independent telencephalic tangential migration (GO:0021826)	10	7	1.22	+	5.75	1.27E-03	1.91E-02
interneuron migration from the subpallium to the cortex (GO:0021830)	10	7	1.22	+	5.75	1.27E-03	1.92E-02
glycosaminoglycan metabolic process (GO:0030203)	152	35	18.50	+	1.89	1.28E-03	1.92E-02
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	10	7	1.22	+	5.75	1.27E-03	1.92E-02
positive regulation of steroid hormone secretion (GO:2000833)	10	7	1.22	+	5.75	1.27E-03	1.92E-02
cardiac muscle cell myoblast differentiation (GO:0060379)	10	7	1.22	+	5.75	1.27E-03	1.92E-02
forebrain neuron development (GO:0021884)	30	12	3.65	+	3.29	1.27E-03	1.92E-02
neurotransmitter uptake (GO:0001504)	30	12	3.65	+	3.29	1.27E-03	1.92E-02
generation of precursor metabolites and energy (GO:0006091)	403	27	49.06	-	.55	1.29E-03	1.93E-02
regulation of catalytic activity (GO:0050790)	2433	353	296.17	+	1.19	1.29E-03	1.93E-02
telomere organization (GO:0032200)	103	2	12.54	-	.16	1.30E-03	1.94E-02
cellular biosynthetic process (GO:0044249)	2715	274	330.49	-	.83	1.30E-03	1.95E-02
biosynthetic process (GO:0009058)	2865	291	348.75	-	.83	1.35E-03	2.02E-02
hormone transport (GO:0009914)	83	23	10.10	+	2.28	1.36E-03	2.03E-02
regulation of protein transport (GO:0051223)	556	97	67.68	+	1.43	1.38E-03	2.05E-02
aorta development (GO:0035904)	53	17	6.45	+	2.63	1.40E-03	2.08E-02
cell fate commitment involved in formation of primary germ layer (GO:0060795)	26	11	3.16	+	3.48	1.41E-03	2.09E-02
retina layer formation (GO:0010842)	26	11	3.16	+	3.48	1.41E-03	2.09E-02
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	91	24	11.08	+	2.17	1.42E-03	2.10E-02
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	7	6	.85	+	7.04	1.42E-03	2.10E-02
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	7	6	.85	+	7.04	1.42E-03	2.10E-02
amylin receptor signaling pathway (GO:0097647)	7	6	.85	+	7.04	1.42E-03	2.10E-02
mesenchymal cell development (GO:0014031)	84	23	10.23	+	2.25	1.44E-03	2.13E-02
endothelial cell differentiation (GO:0045446)	84	23	10.23	+	2.25	1.44E-03	2.13E-02
chromatin assembly or disassembly (GO:0006333)	170	7	20.69	-	.34	1.46E-03	2.16E-02
protein targeting to membrane (GO:0006612)	182	8	22.15	-	.36	1.46E-03	2.16E-02
positive regulation of blood circulation (GO:1903524)	40	14	4.87	+	2.88	1.48E-03	2.18E-02
negative regulation of leukocyte differentiation (GO:1902106)	102	26	12.42	+	2.09	1.49E-03	2.19E-02
regulation of long-term synaptic depression (GO:1900452)	14	8	1.70	+	4.69	1.50E-03	2.20E-02
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	14	8	1.70	+	4.69	1.50E-03	2.20E-02
rhythmic process (GO:0048511)	269	54	32.74	+	1.65	1.50E-03	2.20E-02
regulation of axon guidance (GO:1902667)	14	8	1.70	+	4.69	1.50E-03	2.20E-02
regulation of inflammatory response (GO:0050727)	518	91	63.06	+	1.44	1.50E-03	2.20E-02
intestinal epithelial cell differentiation (GO:0060575)	22	10	2.68	+	3.73	1.51E-03	2.21E-02
endocardial cushion formation (GO:0003272)	22	10	2.68	+	3.73	1.51E-03	2.21E-02
neurotransmitter reuptake (GO:0098810)	22	10	2.68	+	3.73	1.51E-03	2.21E-02
detection of temperature stimulus involved in sensory perception (GO:0050961)	22	10	2.68	+	3.73	1.51E-03	2.21E-02
ribosome assembly (GO:0042255)	62	0	7.55	-	 < 0.01	1.54E-03	2.24E-02
regulation of telomere maintenance via telomere lengthening (GO:1904356)	62	0	7.55	-	 < 0.01	1.54E-03	2.24E-02
detection of mechanical stimulus (GO:0050982)	54	17	6.57	+	2.59	1.56E-03	2.26E-02
parasympathetic nervous system development (GO:0048486)	18	9	2.19	+	4.11	1.56E-03	2.26E-02
metanephric tubule development (GO:0072170)	18	9	2.19	+	4.11	1.56E-03	2.26E-02
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	18	9	2.19	+	4.11	1.56E-03	2.26E-02
specification of animal organ identity (GO:0010092)	18	9	2.19	+	4.11	1.56E-03	2.26E-02
cGMP metabolic process (GO:0046068)	18	9	2.19	+	4.11	1.56E-03	2.27E-02
establishment of protein localization to endoplasmic reticulum (GO:0072599)	116	3	14.12	-	.21	1.57E-03	2.28E-02
protein polyubiquitination (GO:0000209)	325	20	39.56	-	.51	1.59E-03	2.30E-02
vasoconstriction (GO:0042310)	31	12	3.77	+	3.18	1.60E-03	2.30E-02
fear response (GO:0042596)	31	12	3.77	+	3.18	1.60E-03	2.31E-02
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	258	52	31.41	+	1.66	1.65E-03	2.37E-02
regulation of tissue remodeling (GO:0034103)	76	21	9.25	+	2.27	1.66E-03	2.39E-02
regulation of striated muscle cell differentiation (GO:0051153)	86	23	10.47	+	2.20	1.66E-03	2.40E-02
regulation of MAP kinase activity (GO:0043405)	310	60	37.74	+	1.59	1.72E-03	2.47E-02
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	126	30	15.34	+	1.96	1.73E-03	2.49E-02
establishment of protein localization to membrane (GO:0090150)	313	19	38.10	-	.50	1.75E-03	2.51E-02
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	96	2	11.69	-	.17	1.75E-03	2.51E-02
cell-cell signaling involved in cardiac conduction (GO:0086019)	27	11	3.29	+	3.35	1.79E-03	2.56E-02
embryonic camera-type eye morphogenesis (GO:0048596)	27	11	3.29	+	3.35	1.79E-03	2.56E-02
startle response (GO:0001964)	27	11	3.29	+	3.35	1.79E-03	2.56E-02
male gonad development (GO:0008584)	138	32	16.80	+	1.90	1.79E-03	2.56E-02
regulation of sensory perception (GO:0051931)	41	14	4.99	+	2.81	1.79E-03	2.56E-02
regulation of response to wounding (GO:1903034)	162	36	19.72	+	1.83	1.80E-03	2.57E-02
negative regulation of BMP signaling pathway (GO:0030514)	61	18	7.43	+	2.42	1.82E-03	2.60E-02
DNA-templated transcription, elongation (GO:0006354)	79	1	9.62	-	.10	1.84E-03	2.62E-02
negative regulation of chromosome organization (GO:2001251)	79	1	9.62	-	.10	1.84E-03	2.62E-02
cardiac muscle cell action potential (GO:0086001)	49	16	5.96	+	2.68	1.85E-03	2.62E-02
endoderm formation (GO:0001706)	49	16	5.96	+	2.68	1.85E-03	2.62E-02
telomere maintenance (GO:0000723)	99	2	12.05	-	.17	1.85E-03	2.63E-02
antigen receptor-mediated signaling pathway (GO:0050851)	299	18	36.40	-	.49	1.88E-03	2.66E-02
development of primary male sexual characteristics (GO:0046546)	139	32	16.92	+	1.89	1.89E-03	2.66E-02
ventral spinal cord interneuron fate commitment (GO:0060579)	11	7	1.34	+	5.23	1.89E-03	2.67E-02
regulation of cell-substrate adhesion (GO:0010810)	218	45	26.54	+	1.70	1.90E-03	2.67E-02
import across plasma membrane (GO:0098739)	139	32	16.92	+	1.89	1.89E-03	2.67E-02
cell fate commitment involved in pattern specification (GO:0060581)	11	7	1.34	+	5.23	1.89E-03	2.67E-02
olfactory bulb interneuron differentiation (GO:0021889)	11	7	1.34	+	5.23	1.89E-03	2.67E-02
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	11	7	1.34	+	5.23	1.89E-03	2.67E-02
negative regulation of cardiocyte differentiation (GO:1905208)	11	7	1.34	+	5.23	1.89E-03	2.68E-02
axon ensheathment (GO:0008366)	108	27	13.15	+	2.05	1.91E-03	2.68E-02
regulation of mesenchymal cell apoptotic process (GO:2001053)	11	7	1.34	+	5.23	1.89E-03	2.68E-02
ensheathment of neurons (GO:0007272)	108	27	13.15	+	2.05	1.91E-03	2.68E-02
metanephric tubule morphogenesis (GO:0072173)	11	7	1.34	+	5.23	1.89E-03	2.68E-02
regulation of protein kinase B signaling (GO:0051896)	235	48	28.61	+	1.68	1.93E-03	2.71E-02
negative regulation of myeloid cell differentiation (GO:0045638)	80	22	9.74	+	2.26	1.93E-03	2.71E-02
response to nutrient levels (GO:0031667)	501	88	60.99	+	1.44	1.96E-03	2.73E-02
cyclic nucleotide biosynthetic process (GO:0009190)	23	10	2.80	+	3.57	1.96E-03	2.74E-02
positive regulation of mesenchymal cell proliferation (GO:0002053)	23	10	2.80	+	3.57	1.96E-03	2.74E-02
cyclic purine nucleotide metabolic process (GO:0052652)	23	10	2.80	+	3.57	1.96E-03	2.74E-02
innervation (GO:0060384)	23	10	2.80	+	3.57	1.96E-03	2.74E-02
Notch signaling pathway (GO:0007219)	119	29	14.49	+	2.00	1.97E-03	2.75E-02
response to vitamin (GO:0033273)	88	23	10.71	+	2.15	1.98E-03	2.75E-02
positive regulation of fat cell differentiation (GO:0045600)	64	19	7.79	+	2.44	2.01E-03	2.79E-02
response to biotic stimulus (GO:0009607)	1547	146	188.31	-	.78	2.01E-03	2.80E-02
regulation of translation (GO:0006417)	415	29	50.52	-	.57	2.02E-03	2.81E-02
aromatic compound catabolic process (GO:0019439)	438	31	53.32	-	.58	2.03E-03	2.81E-02
cellular response to peptide (GO:1901653)	339	64	41.27	+	1.55	2.03E-03	2.81E-02
regulation of exocytosis (GO:0017157)	207	43	25.20	+	1.71	2.08E-03	2.87E-02
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	15	8	1.83	+	4.38	2.08E-03	2.87E-02
enteric nervous system development (GO:0048484)	15	8	1.83	+	4.38	2.08E-03	2.87E-02
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	15	8	1.83	+	4.38	2.08E-03	2.87E-02
negative regulation of bone remodeling (GO:0046851)	19	9	2.31	+	3.89	2.08E-03	2.87E-02
dentate gyrus development (GO:0021542)	15	8	1.83	+	4.38	2.08E-03	2.87E-02
regulation of response to external stimulus (GO:0032101)	1199	186	145.95	+	1.27	2.08E-03	2.88E-02
embryonic camera-type eye development (GO:0031076)	37	13	4.50	+	2.89	2.10E-03	2.88E-02
animal organ formation (GO:0048645)	37	13	4.50	+	2.89	2.10E-03	2.88E-02
negative regulation of hormone secretion (GO:0046888)	65	19	7.91	+	2.40	2.13E-03	2.92E-02
regulation of regulated secretory pathway (GO:1903305)	144	33	17.53	+	1.88	2.14E-03	2.94E-02
posttranscriptional regulation of gene expression (GO:0010608)	581	45	70.72	-	.64	2.14E-03	2.94E-02
negative regulation of defense response (GO:0031348)	402	73	48.93	+	1.49	2.18E-03	2.98E-02
odontogenesis of dentin-containing tooth (GO:0042475)	82	22	9.98	+	2.20	2.18E-03	2.98E-02
female pregnancy (GO:0007565)	182	39	22.15	+	1.76	2.18E-03	2.98E-02
protein targeting to ER (GO:0045047)	112	3	13.63	-	.22	2.22E-03	3.03E-02
adult walking behavior (GO:0007628)	28	11	3.41	+	3.23	2.25E-03	3.05E-02
forebrain neuron fate commitment (GO:0021877)	8	6	.97	+	6.16	2.25E-03	3.06E-02
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	8	6	.97	+	6.16	2.25E-03	3.06E-02
nuclear chromosome segregation (GO:0098813)	227	12	27.63	-	.43	2.26E-03	3.06E-02
calcitonin family receptor signaling pathway (GO:0097646)	8	6	.97	+	6.16	2.25E-03	3.06E-02
interneuron migration (GO:1904936)	8	6	.97	+	6.16	2.25E-03	3.06E-02
glial cell development (GO:0021782)	111	27	13.51	+	2.00	2.24E-03	3.06E-02
paraxial mesoderm formation (GO:0048341)	8	6	.97	+	6.16	2.25E-03	3.07E-02
regulation of serotonin secretion (GO:0014062)	8	6	.97	+	6.16	2.25E-03	3.07E-02
positive regulation of AMPA receptor activity (GO:2000969)	8	6	.97	+	6.16	2.25E-03	3.07E-02
regulation of sodium ion transmembrane transport (GO:1902305)	66	19	8.03	+	2.36	2.28E-03	3.09E-02
protein transmembrane transport (GO:0071806)	58	0	7.06	-	 < 0.01	2.31E-03	3.13E-02
regulation of phospholipase activity (GO:0010517)	73	20	8.89	+	2.25	2.33E-03	3.15E-02
sinoatrial node cell development (GO:0060931)	5	5	.61	+	8.21	2.36E-03	3.18E-02
negative regulation of apoptotic process involved in development (GO:1904746)	5	5	.61	+	8.21	2.36E-03	3.18E-02
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	5	5	.61	+	8.21	2.36E-03	3.19E-02
Wnt signaling pathway (GO:0016055)	350	65	42.61	+	1.53	2.39E-03	3.22E-02
cell-cell signaling by wnt (GO:0198738)	350	65	42.61	+	1.53	2.39E-03	3.22E-02
positive regulation of vasoconstriction (GO:0045907)	33	12	4.02	+	2.99	2.44E-03	3.28E-02
positive regulation of MAP kinase activity (GO:0043406)	232	47	28.24	+	1.66	2.50E-03	3.35E-02
diacylglycerol metabolic process (GO:0046339)	24	10	2.92	+	3.42	2.51E-03	3.37E-02
cellular response to vitamin (GO:0071295)	24	10	2.92	+	3.42	2.51E-03	3.37E-02
lymph vessel development (GO:0001945)	24	10	2.92	+	3.42	2.51E-03	3.37E-02
somatic stem cell population maintenance (GO:0035019)	52	16	6.33	+	2.53	2.52E-03	3.38E-02
stem cell development (GO:0048864)	84	22	10.23	+	2.15	2.53E-03	3.39E-02
forelimb morphogenesis (GO:0035136)	38	13	4.63	+	2.81	2.54E-03	3.39E-02
cardiac muscle cell action potential involved in contraction (GO:0086002)	38	13	4.63	+	2.81	2.54E-03	3.39E-02
negative regulation of hemopoiesis (GO:1903707)	104	26	12.66	+	2.05	2.55E-03	3.40E-02
response to organophosphorus (GO:0046683)	136	31	16.56	+	1.87	2.56E-03	3.41E-02
vesicle targeting (GO:0006903)	94	2	11.44	-	.17	2.57E-03	3.42E-02
negative regulation of muscle cell differentiation (GO:0051148)	58	17	7.06	+	2.41	2.58E-03	3.44E-02
regulation of establishment of protein localization (GO:0070201)	581	99	70.72	+	1.40	2.59E-03	3.45E-02
hematopoietic or lymphoid organ development (GO:0048534)	633	106	77.05	+	1.38	2.62E-03	3.48E-02
protein acetylation (GO:0006473)	138	5	16.80	-	.30	2.64E-03	3.50E-02
response to ionizing radiation (GO:0010212)	148	6	18.02	-	.33	2.66E-03	3.53E-02
regulation of biomineralization (GO:0110149)	95	24	11.56	+	2.08	2.68E-03	3.55E-02
chromatin assembly (GO:0031497)	150	6	18.26	-	.33	2.68E-03	3.55E-02
activation of innate immune response (GO:0002218)	150	6	18.26	-	.33	2.68E-03	3.55E-02
telencephalon regionalization (GO:0021978)	12	7	1.46	+	4.79	2.72E-03	3.55E-02
nitric oxide mediated signal transduction (GO:0007263)	20	9	2.43	+	3.70	2.72E-03	3.55E-02
regulation of apoptotic process involved in development (GO:1904748)	12	7	1.46	+	4.79	2.72E-03	3.56E-02
trabecula formation (GO:0060343)	20	9	2.43	+	3.70	2.72E-03	3.56E-02
inhibitory synapse assembly (GO:1904862)	12	7	1.46	+	4.79	2.72E-03	3.56E-02
regulation of steroid hormone secretion (GO:2000831)	20	9	2.43	+	3.70	2.72E-03	3.56E-02
midbrain dopaminergic neuron differentiation (GO:1904948)	12	7	1.46	+	4.79	2.72E-03	3.56E-02
peripheral nervous system neuron differentiation (GO:0048934)	12	7	1.46	+	4.79	2.72E-03	3.56E-02
peripheral nervous system neuron development (GO:0048935)	12	7	1.46	+	4.79	2.72E-03	3.57E-02
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	46	15	5.60	+	2.68	2.71E-03	3.57E-02
transcription elongation from RNA polymerase II promoter (GO:0006368)	75	1	9.13	-	.11	2.70E-03	3.57E-02
renal system process (GO:0003014)	116	28	14.12	+	1.98	2.71E-03	3.57E-02
regulation of apoptotic process involved in morphogenesis (GO:1902337)	12	7	1.46	+	4.79	2.72E-03	3.57E-02
positive regulation of signaling receptor activity (GO:2000273)	46	15	5.60	+	2.68	2.71E-03	3.57E-02
mechanoreceptor differentiation (GO:0042490)	68	19	8.28	+	2.30	2.70E-03	3.57E-02
cardioblast differentiation (GO:0010002)	12	7	1.46	+	4.79	2.72E-03	3.57E-02
cranial nerve structural organization (GO:0021604)	12	7	1.46	+	4.79	2.72E-03	3.58E-02
mitochondrial transport (GO:0006839)	235	13	28.61	-	.45	2.75E-03	3.58E-02
negative regulation of developmental growth (GO:0048640)	106	26	12.90	+	2.01	2.76E-03	3.60E-02
walking behavior (GO:0090659)	29	11	3.53	+	3.12	2.81E-03	3.65E-02
regulation of excitatory synapse assembly (GO:1904889)	16	8	1.95	+	4.11	2.83E-03	3.66E-02
vascular associated smooth muscle cell differentiation (GO:0035886)	16	8	1.95	+	4.11	2.83E-03	3.67E-02
stress response to copper ion (GO:1990169)	16	8	1.95	+	4.11	2.83E-03	3.67E-02
preganglionic parasympathetic fiber development (GO:0021783)	16	8	1.95	+	4.11	2.83E-03	3.67E-02
detoxification of copper ion (GO:0010273)	16	8	1.95	+	4.11	2.83E-03	3.67E-02
transmission of nerve impulse (GO:0019226)	53	16	6.45	+	2.48	2.85E-03	3.69E-02
aminoglycan metabolic process (GO:0006022)	166	36	20.21	+	1.78	2.87E-03	3.72E-02
response to ethanol (GO:0045471)	141	32	17.16	+	1.86	2.89E-03	3.73E-02
cerebral cortex development (GO:0021987)	118	28	14.36	+	1.95	2.91E-03	3.76E-02
response to purine-containing compound (GO:0014074)	154	34	18.75	+	1.81	2.95E-03	3.80E-02
long-term memory (GO:0007616)	34	12	4.14	+	2.90	2.98E-03	3.83E-02
response to morphine (GO:0043278)	34	12	4.14	+	2.90	2.98E-03	3.83E-02
activation of protein kinase B activity (GO:0032148)	34	12	4.14	+	2.90	2.98E-03	3.84E-02
response to isoquinoline alkaloid (GO:0014072)	34	12	4.14	+	2.90	2.98E-03	3.84E-02
negative regulation of insulin secretion (GO:0046676)	39	13	4.75	+	2.74	3.05E-03	3.92E-02
embryonic axis specification (GO:0000578)	39	13	4.75	+	2.74	3.05E-03	3.92E-02
regulation of oligodendrocyte differentiation (GO:0048713)	39	13	4.75	+	2.74	3.05E-03	3.92E-02
positive regulation of lipid kinase activity (GO:0090218)	39	13	4.75	+	2.74	3.05E-03	3.93E-02
positive regulation of osteoblast differentiation (GO:0045669)	62	18	7.55	+	2.38	3.07E-03	3.93E-02
neural crest cell development (GO:0014032)	79	21	9.62	+	2.18	3.07E-03	3.93E-02
response to cAMP (GO:0051591)	97	24	11.81	+	2.03	3.08E-03	3.93E-02
positive regulation of endothelial cell migration (GO:0010595)	108	26	13.15	+	1.98	3.08E-03	3.94E-02
regulation of ERK1 and ERK2 cascade (GO:0070372)	294	56	35.79	+	1.56	3.09E-03	3.95E-02
regulation of wound healing (GO:0061041)	131	30	15.95	+	1.88	3.11E-03	3.97E-02
cell proliferation in forebrain (GO:0021846)	25	10	3.04	+	3.29	3.18E-03	4.05E-02
negative regulation of protein phosphorylation (GO:0001933)	353	65	42.97	+	1.51	3.18E-03	4.05E-02
chondroitin sulfate biosynthetic process (GO:0030206)	25	10	3.04	+	3.29	3.18E-03	4.05E-02
vesicle organization (GO:0016050)	313	20	38.10	-	.52	3.23E-03	4.11E-02
negative regulation of phosphorylation (GO:0042326)	395	71	48.08	+	1.48	3.25E-03	4.12E-02
neuron recognition (GO:0008038)	48	15	5.84	+	2.57	3.26E-03	4.13E-02
catechol-containing compound metabolic process (GO:0009712)	48	15	5.84	+	2.57	3.26E-03	4.14E-02
catecholamine metabolic process (GO:0006584)	48	15	5.84	+	2.57	3.26E-03	4.14E-02
regulation of cell size (GO:0008361)	185	39	22.52	+	1.73	3.28E-03	4.15E-02
positive regulation of cell death (GO:0010942)	638	106	77.66	+	1.36	3.29E-03	4.16E-02
positive regulation of insulin secretion (GO:0032024)	80	21	9.74	+	2.16	3.29E-03	4.16E-02
hypothalamus cell differentiation (GO:0021979)	9	6	1.10	+	5.48	3.41E-03	4.27E-02
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	9	6	1.10	+	5.48	3.41E-03	4.28E-02
cardiac pacemaker cell differentiation (GO:0060920)	9	6	1.10	+	5.48	3.41E-03	4.28E-02
primitive streak formation (GO:0090009)	9	6	1.10	+	5.48	3.41E-03	4.28E-02
receptor diffusion trapping (GO:0098953)	9	6	1.10	+	5.48	3.41E-03	4.29E-02
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	9	6	1.10	+	5.48	3.41E-03	4.29E-02
neurotransmitter receptor diffusion trapping (GO:0099628)	9	6	1.10	+	5.48	3.41E-03	4.29E-02
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	9	6	1.10	+	5.48	3.41E-03	4.30E-02
spinal cord motor neuron cell fate specification (GO:0021520)	9	6	1.10	+	5.48	3.41E-03	4.30E-02
mitotic sister chromatid segregation (GO:0000070)	121	4	14.73	-	.27	3.44E-03	4.30E-02
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	9	6	1.10	+	5.48	3.41E-03	4.30E-02
regulation of heart morphogenesis (GO:2000826)	9	6	1.10	+	5.48	3.41E-03	4.31E-02
regulation of lipid transport (GO:0032368)	133	30	16.19	+	1.85	3.44E-03	4.31E-02
facial nerve structural organization (GO:0021612)	9	6	1.10	+	5.48	3.41E-03	4.31E-02
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	30	11	3.65	+	3.01	3.47E-03	4.32E-02
cranial nerve morphogenesis (GO:0021602)	30	11	3.65	+	3.01	3.47E-03	4.33E-02
olfactory bulb development (GO:0021772)	30	11	3.65	+	3.01	3.47E-03	4.33E-02
regulation of telomere maintenance via telomerase (GO:0032210)	54	0	6.57	-	 < 0.01	3.49E-03	4.34E-02
nuclear DNA replication (GO:0033260)	54	0	6.57	-	 < 0.01	3.49E-03	4.34E-02
inner mitochondrial membrane organization (GO:0007007)	54	0	6.57	-	 < 0.01	3.49E-03	4.35E-02
linoleic acid metabolic process (GO:0043651)	21	9	2.56	+	3.52	3.52E-03	4.38E-02
reactive oxygen species metabolic process (GO:0072593)	101	25	12.29	+	2.03	3.53E-03	4.38E-02
blastoderm segmentation (GO:0007350)	21	9	2.56	+	3.52	3.52E-03	4.38E-02
cell cycle DNA replication (GO:0044786)	55	0	6.70	-	 < 0.01	3.58E-03	4.44E-02
protein import (GO:0017038)	158	7	19.23	-	.36	3.62E-03	4.48E-02
gene silencing by RNA (GO:0031047)	89	2	10.83	-	.18	3.63E-03	4.49E-02
RNA methylation (GO:0001510)	88	2	10.71	-	.19	3.63E-03	4.50E-02
skeletal muscle cell differentiation (GO:0035914)	49	15	5.96	+	2.51	3.64E-03	4.50E-02
protein folding (GO:0006457)	233	13	28.36	-	.46	3.64E-03	4.50E-02
mitochondrial membrane organization (GO:0007006)	146	6	17.77	-	.34	3.65E-03	4.50E-02
response to glucocorticoid (GO:0051384)	149	33	18.14	+	1.82	3.70E-03	4.57E-02
regulation of phagocytosis (GO:0050764)	92	23	11.20	+	2.05	3.72E-03	4.58E-02
negative regulation of response to wounding (GO:1903035)	92	23	11.20	+	2.05	3.72E-03	4.59E-02
mammary gland epithelial cell differentiation (GO:0060644)	17	8	2.07	+	3.87	3.77E-03	4.61E-02
mesenchymal cell proliferation (GO:0010463)	17	8	2.07	+	3.87	3.77E-03	4.62E-02
regulation of dopamine metabolic process (GO:0042053)	17	8	2.07	+	3.87	3.77E-03	4.62E-02
regulation of catecholamine metabolic process (GO:0042069)	17	8	2.07	+	3.87	3.77E-03	4.62E-02
stabilization of membrane potential (GO:0030322)	17	8	2.07	+	3.87	3.77E-03	4.63E-02
positive regulation of voltage-gated potassium channel activity (GO:1903818)	17	8	2.07	+	3.87	3.77E-03	4.63E-02
reflex (GO:0060004)	17	8	2.07	+	3.87	3.77E-03	4.63E-02
atrioventricular canal development (GO:0036302)	13	7	1.58	+	4.42	3.79E-03	4.63E-02
metanephric nephron epithelium development (GO:0072243)	17	8	2.07	+	3.87	3.77E-03	4.64E-02
regulation of postsynaptic density assembly (GO:0099151)	13	7	1.58	+	4.42	3.79E-03	4.64E-02
negative regulation of amino acid transport (GO:0051956)	13	7	1.58	+	4.42	3.79E-03	4.64E-02
response to monoamine (GO:0071867)	103	25	12.54	+	1.99	3.81E-03	4.64E-02
response to catecholamine (GO:0071869)	103	25	12.54	+	1.99	3.81E-03	4.65E-02
positive regulation of protein secretion (GO:0050714)	138	31	16.80	+	1.85	3.88E-03	4.73E-02
positive regulation of lipase activity (GO:0060193)	74	20	9.01	+	2.22	3.91E-03	4.76E-02
cerebral cortex GABAergic interneuron migration (GO:0021853)	6	5	.73	+	6.85	3.94E-03	4.77E-02
biological process involved in interspecies interaction between organisms (GO:0044419)	1593	154	193.91	-	.79	3.95E-03	4.78E-02
corticospinal tract morphogenesis (GO:0021957)	6	5	.73	+	6.85	3.94E-03	4.78E-02
pancreatic A cell differentiation (GO:0003310)	6	5	.73	+	6.85	3.94E-03	4.78E-02
stem cell fate commitment (GO:0048865)	6	5	.73	+	6.85	3.94E-03	4.78E-02
regulation of heart induction (GO:0090381)	6	5	.73	+	6.85	3.94E-03	4.79E-02
development of primary female sexual characteristics (GO:0046545)	93	23	11.32	+	2.03	3.96E-03	4.79E-02
regulation of microvillus assembly (GO:0032534)	6	5	.73	+	6.85	3.94E-03	4.79E-02
negative regulation of blood vessel morphogenesis (GO:2000181)	104	25	12.66	+	1.97	4.00E-03	4.79E-02
axis elongation (GO:0003401)	26	10	3.16	+	3.16	3.98E-03	4.79E-02
glomerular mesangial cell differentiation (GO:0072008)	6	5	.73	+	6.85	3.94E-03	4.80E-02
cerebellum development (GO:0021549)	104	25	12.66	+	1.97	4.00E-03	4.80E-02
negative regulation of anion transport (GO:1903792)	26	10	3.16	+	3.16	3.98E-03	4.80E-02
cell communication involved in cardiac conduction (GO:0086065)	43	14	5.23	+	2.67	3.99E-03	4.80E-02
negative regulation of stem cell population maintenance (GO:1902455)	6	5	.73	+	6.85	3.94E-03	4.80E-02
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	208	42	25.32	+	1.66	4.00E-03	4.80E-02
opsonization (GO:0008228)	72	1	8.76	-	.11	4.00E-03	4.80E-02
developmental induction (GO:0031128)	26	10	3.16	+	3.16	3.98E-03	4.80E-02
modulation of excitatory postsynaptic potential (GO:0098815)	43	14	5.23	+	2.67	3.99E-03	4.80E-02
regulation of non-canonical Wnt signaling pathway (GO:2000050)	26	10	3.16	+	3.16	3.98E-03	4.80E-02
pharyngeal system development (GO:0060037)	26	10	3.16	+	3.16	3.98E-03	4.81E-02
ribosomal small subunit biogenesis (GO:0042274)	73	1	8.89	-	.11	4.08E-03	4.88E-02
transcription-coupled nucleotide-excision repair (GO:0006283)	73	1	8.89	-	.11	4.08E-03	4.88E-02
endoderm development (GO:0007492)	75	20	9.13	+	2.19	4.09E-03	4.89E-02
regulation of response to biotic stimulus (GO:0002831)	434	32	52.83	-	.61	4.13E-03	4.94E-02
